<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92078</article-id><article-id pub-id-type="doi">10.7554/eLife.92078</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92078.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Physics of Living Systems</subject></subj-group></article-categories><title-group><article-title>Caveolin-1 protects endothelial cells from extensive expansion of transcellular tunnel by stiffening the plasma membrane</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-333220"><name><surname>Morel</surname><given-names>Camille</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-333221"><name><surname>Lemerle</surname><given-names>Eline</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-110155"><name><surname>Tsai</surname><given-names>Feng-Ching</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6869-5254</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-333222"><name><surname>Obadia</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248221"><name><surname>Srivastava</surname><given-names>Nishit</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4177-6123</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-333223"><name><surname>Marechal</surname><given-names>Maud</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-333224"><name><surname>Salles</surname><given-names>Audrey</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-333225"><name><surname>Albert</surname><given-names>Marvin</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-59198"><name><surname>Stefani</surname><given-names>Caroline</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3420-432X</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-333226"><name><surname>Benito</surname><given-names>Yvonne</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-171840"><name><surname>Vandenesch</surname><given-names>François</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9412-7106</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-19533"><name><surname>Lamaze</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157983"><name><surname>Vassilopoulos</surname><given-names>Stéphane</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0172-330X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1913"><name><surname>Piel</surname><given-names>Matthieu</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28400"><name><surname>Bassereau</surname><given-names>Patricia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8544-6778</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-59199"><name><surname>Gonzalez-Rodriguez</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6152-2222</contrib-id><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-332513"><name><surname>Leduc</surname><given-names>Cecile</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1806-4120</contrib-id><email>cecile.leduc@ijm.fr</email><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-110284"><name><surname>Lemichez</surname><given-names>Emmanuel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9080-7761</contrib-id><email>elemiche@pasteur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, CNRS UMR6047, Inserm U1306, Unité des Toxines Bactériennes, Département de Microbiologie</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02en5vm52</institution-id><institution>Sorbonne Université, INSERM UMR974, Institut de Myologie, Centre de Recherche en Myologie</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04t0gwh46</institution-id><institution>Institut Curie, PSL Research University, CNRS UMR168, Physics of Cells and Cancer Laboratory</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, G5 Infectious Diseases Epidemiology and Analytics</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02en5vm52</institution-id><institution>Institut Curie and Institut Pierre Gilles de Gennes, PSL Research University, Sorbonne University</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, Photonic Bio-Imaging, Centre de Ressources et Recherches Technologiques (UTechS-PBI, C2RT)</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Institut Pasteur, Université Paris Cité, Image Analysis Hub</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04j9rp686</institution-id><institution>Benaroya Research Institute at Virginia Mason, Department of Immunology</institution></institution-wrap><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01502ca60</institution-id><institution>Centre National de Référence des Staphylocoques, Hospices Civiles de Lyon</institution></institution-wrap><addr-line><named-content content-type="city">Lyon</named-content></addr-line><country>France</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/029brtt94</institution-id><institution>CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France</institution></institution-wrap><addr-line><named-content content-type="city">Lyon</named-content></addr-line><country>France</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vjkv261</institution-id><institution>Institut Curie, PSL Research University, INSERM U1143, CNRS UMR3666, Membrane Mechanics and Dynamics of Intracellular Signaling Laboratory</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04vfs2w97</institution-id><institution>Université de Lorraine, LCP-A2MC</institution></institution-wrap><addr-line><named-content content-type="city">Metz</named-content></addr-line><country>France</country></aff><aff id="aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02c5gc203</institution-id><institution>Université Paris Cité, Institut Jacques Monod, CNRS UMR7592</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Mukherjee</surname><given-names>Shaeri</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>University of California, San Francisco</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>22</day><month>03</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP92078</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-08-31"><day>31</day><month>08</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-09-01"><day>01</day><month>09</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.09.27.509635"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-24"><day>24</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92078.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-02-19"><day>19</day><month>02</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92078.2"/></event></pub-history><permissions><copyright-statement>© 2023, Morel et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Morel et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92078-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92078-figures-v1.pdf"/><abstract><p>Large transcellular pores elicited by bacterial mono-ADP-ribosyltransferase (mART) exotoxins inhibiting the small RhoA GTPase compromise the endothelial barrier. Recent advances in biophysical modeling point toward membrane tension and bending rigidity as the minimal set of mechanical parameters determining the nucleation and maximal size of transendothelial cell macroaperture (TEM) tunnels induced by bacterial RhoA-targeting mART exotoxins. We report that cellular depletion of caveolin-1, the membrane-embedded building block of caveolae, and depletion of cavin-1, the master regulator of caveolae invaginations, increase the number of TEMs per cell. The enhanced occurrence of TEM nucleation events correlates with a reduction in cell height due to the increase in cell spreading and decrease in cell volume, which, together with the disruption of RhoA-driven F-actin meshwork, favor membrane apposition for TEM nucleation. Strikingly, caveolin-1 specifically controls the opening speed of TEMs, leading to their dramatic 5.4-fold larger widening. Consistent with the increase in TEM density and width in siCAV1 cells, we record a higher lethality in CAV1 KO mice subjected to a catalytically active mART exotoxin targeting RhoA during staphylococcal bloodstream infection. Combined theoretical modeling with independent biophysical measurements of plasma membrane bending rigidity points toward a specific contribution of caveolin-1 to membrane stiffening in addition to the role of cavin-1/caveolin-1-dependent caveolae in the control of membrane tension homeostasis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>caveolin-1</kwd><kwd>plasma membrane mechanics</kwd><kwd>transendothelial cell macroaperture</kwd><kwd>bacterial toxin</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-10-LABX-62-IBEID</award-id><principal-award-recipient><name><surname>Lemichez</surname><given-names>Emmanuel</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100023300</institution-id><institution>Institut Pasteur</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Lemichez</surname><given-names>Emmanuel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Caveolin-1 controls the width of transendothelial cell tunnels via a direct or indirect effect on membrane bending rigidity.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The endothelial cell monolayer lining the inner surface of the vascular tree forms an active semipermeable barrier that actively responds to hemodynamic forces to control blood pressure (<xref ref-type="bibr" rid="bib1">Aird, 2007a</xref>; <xref ref-type="bibr" rid="bib2">Aird, 2007b</xref>). Regulation of the endothelial barrier involves a bidirectional interplay between actomyosin cytoskeleton and plasma membrane mechanics, which together control paracellular exchanges at cell–cell junctions (<xref ref-type="bibr" rid="bib32">Komarova et al., 2017</xref>), as well as transcellular exchanges through less-characterized transcellular openings (<xref ref-type="bibr" rid="bib1">Aird, 2007a</xref>; <xref ref-type="bibr" rid="bib2">Aird, 2007b</xref>; <xref ref-type="bibr" rid="bib26">Guo et al., 2016</xref>). Defining how membrane mechanical parameters affect the dynamics of opening and widening of transendothelial pores will help better define the role of these openings both physiological and pathophysiological processes.</p><p>Large transcellular pores in the endothelium can contribute to aqueous humor outflow in the eyes, can form during the diapedesis of leukocytes, or appear when endothelial cells are intoxicated by several bacterial toxins known to breach the endothelial barrier (<xref ref-type="bibr" rid="bib36">Lemichez et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Braakman et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Barzilai et al., 2017</xref>). Bacterial mono-ADP-ribosyltransferases (mART) exotoxins, which catalyze the post-translational modification of the small GTPase RhoA for inhibition, induce the spontaneous formation of transendothelial cell macroaperture (TEM) tunnels up to 10–20 µm in diameter (<xref ref-type="bibr" rid="bib8">Boyer et al., 2006</xref>; <xref ref-type="bibr" rid="bib24">Gonzalez-Rodriguez et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Maddugoda et al., 2011</xref>). This group of mART includes the exotoxin C3 (ExoC3) from <italic>Clostridium botulinum</italic> and the epidermal differentiation inhibitors (EDIN) A, B, and C close homologs from <italic>Staphylococcus aureus</italic> (<xref ref-type="bibr" rid="bib69">Sugai et al., 1992</xref>; <xref ref-type="bibr" rid="bib11">Chardin et al., 1989</xref>; <xref ref-type="bibr" rid="bib53">Paterson et al., 1990</xref>). The intravenous injection of EDIN or ExoC3 triggers vascular leakage (<xref ref-type="bibr" rid="bib8">Boyer et al., 2006</xref>; <xref ref-type="bibr" rid="bib60">Rolando et al., 2009</xref>). Cumulative evidence also indicates that EDIN favors the translocation of <italic>S. aureus</italic> through vascular tissues for dissemination (<xref ref-type="bibr" rid="bib47">Munro et al., 2010</xref>; <xref ref-type="bibr" rid="bib12">Courjon et al., 2015</xref>). Although TEM tunnels have not yet been visualized <italic>in vivo</italic>, they form <italic>ex vivo</italic> in the endothelium lining the inner surface of rat aortas either infected with <italic>S. aureus</italic> producing the RhoA-targeting EDIN mART or treated with EDIN (<xref ref-type="bibr" rid="bib8">Boyer et al., 2006</xref>). Mechanistically, the inhibition of RhoA signaling by bacterial mART exotoxins disrupts contractile actomyosin stress fibers, which otherwise stiffen in response to shear forces exerted by the blood flow that tends to compress cells (<xref ref-type="bibr" rid="bib8">Boyer et al., 2006</xref>; <xref ref-type="bibr" rid="bib24">Gonzalez-Rodriguez et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Maddugoda et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Sugai et al., 1992</xref>; <xref ref-type="bibr" rid="bib11">Chardin et al., 1989</xref>). In line with this, compressive mechanical forces applied to the apical region of endothelial cells bring into close contact the apical and basal plasma membranes to nucleate transcellular pores (<xref ref-type="bibr" rid="bib48">Ng et al., 2017</xref>). Although force-induced nucleation of TEMs can be triggered in the absence of inhibition of RhoA, the magnitude of the force required to mechanically open TEMs dramatically decreases when RhoA is inhibited (<xref ref-type="bibr" rid="bib48">Ng et al., 2017</xref>). This led to postulate that TEMs form because of a disruption of actomyosin stress fibers under the control of RhoA, which concur to reduce the height of cells as they spread out (<xref ref-type="bibr" rid="bib8">Boyer et al., 2006</xref>; <xref ref-type="bibr" rid="bib71">Tsai et al., 2022</xref>). The physical mechanisms that set both the nucleation of TEMs and their maximal width remain to be ascertained experimentally.</p><p>TEMs represent a remarkable model system to identify the molecular machinery that controls cell mechanics (<xref ref-type="bibr" rid="bib24">Gonzalez-Rodriguez et al., 2020</xref>). Our current view of the mechanical forces at play in the opening of TEMs largely arises from the phenomenological analogy drawn between TEM tunnel opening and the formation of dry patches in viscous liquid forced to spread on a solid surface, a physical phenomenon referred to as liquid dewetting (<xref ref-type="bibr" rid="bib23">Gonzalez-Rodriguez et al., 2012</xref>). Notably, the analogy drawn between liquid and cellular dewetting suggests that the increase in membrane tension in response to cell spreading is the driving force of TEM nucleation also contributing to define the initial speed of opening, that is, before that membrane tension relaxation around TEM edges and build-up of an actomyosin bundle encircling TEMs counteract the opening (<xref ref-type="bibr" rid="bib43">Maddugoda et al., 2011</xref>; <xref ref-type="bibr" rid="bib23">Gonzalez-Rodriguez et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Stefani et al., 2017</xref>). Of note, the high curvature of the plasma membrane at the edge of TEMs also points toward a contribution of membrane bending rigidity, that is, the energy required to locally bend the membrane surface, in their dynamics. Experimental evidence is still required to ascertain the roles of membrane tension and bending rigidity in the dynamics of TEM tunnel nucleation and enlargement.</p><p>Caveolae are mechano-regulators of the plasma membrane that spontaneously flatten to accommodate acute mechanical loads and thereby prevent membrane rupturing (<xref ref-type="bibr" rid="bib64">Sinha et al., 2011</xref>; <xref ref-type="bibr" rid="bib51">Parton et al., 2020a</xref>). Caveolin oligomers are essential components of caveolae pits (<xref ref-type="bibr" rid="bib50">Parton et al., 2006</xref>; <xref ref-type="bibr" rid="bib55">Porta et al., 2022</xref>). Caveolin-1 homo-oligomers form flat discoid complexes embedded into the inner leaflet of the membrane (<xref ref-type="bibr" rid="bib55">Porta et al., 2022</xref>). The process of invagination of caveolar pits of 50–100 nm diameter involves the association of caveolin-1 with cavin-1 cytosolic structural protein (also referred to as PTRF) (<xref ref-type="bibr" rid="bib40">Ludwig et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Ariotti et al., 2015</xref>; <xref ref-type="bibr" rid="bib41">Ludwig et al., 2016</xref>; <xref ref-type="bibr" rid="bib74">Yang and Scarlata, 2017</xref>; <xref ref-type="bibr" rid="bib34">Lamaze et al., 2017</xref>). Caveolae pits are further stabilized at their neck by the assembly of a ring of dynamin-like EHD2 oligomers (<xref ref-type="bibr" rid="bib14">Daumke et al., 2007</xref>; <xref ref-type="bibr" rid="bib75">Yeow et al., 2017</xref>; <xref ref-type="bibr" rid="bib49">Nishimura and Suetsugu, 2022</xref>). In endothelial cells, the crosstalk between caveolin-1 and RhoA during actomyosin contractility leads to critical mechano-sensing and adaptation to hemodynamic forces (<xref ref-type="bibr" rid="bib76">Yu et al., 2006</xref>; <xref ref-type="bibr" rid="bib15">Del Pozo et al., 2021</xref>). For example, caveolin-1-deficient mice undergo an increase in the endothelial nitric oxide (eNOS) signaling that is critical to activate RhoA signaling via nitration-mediated inhibition of the GTPase-activating protein (GAP) activity of p190RhoGAP-A (<xref ref-type="bibr" rid="bib63">Siddiqui et al., 2011</xref>; <xref ref-type="bibr" rid="bib58">Razani et al., 2001</xref>; <xref ref-type="bibr" rid="bib46">Miyawaki-Shimizu et al., 2006</xref>). Cell biology and epidemiological studies have started to establish the importance of caveolin-1 in host‒pathogen interactions (<xref ref-type="bibr" rid="bib42">Machado et al., 2012</xref>; <xref ref-type="bibr" rid="bib66">Spaan et al., 2022</xref>; <xref ref-type="bibr" rid="bib45">Medina et al., 2006</xref>). Considering the protective function of caveolae membrane invaginations in ensuring membrane tension homeostasis in response to acute mechanical loads (<xref ref-type="bibr" rid="bib64">Sinha et al., 2011</xref>; <xref ref-type="bibr" rid="bib17">Dewulf et al., 2019</xref>), caveolin-1 and cavin-1 represent potential mechano-regulators of transcellular pore dynamics.</p><p>Using cutting-edge microscopy techniques, we establish that endothelial cells treated with RhoA-targeting mART display caveolae pits at the ventral part of the plasma membrane and a loose F-actin meshwork that frame large cytosolic zones devoid of F-actin. We report that the disruption of caveolae and depletion of caveolin-1, using siRNA-targeting cavin-1 or caveolin-1, respectively, increases the number of TEM per cell. We establish that the increase in TEM opening correlates with a decrease in cell volume concomitant with cell spreading, which concur to a decrease in cell height. Strikingly, we establish that caveolin-1, contrary to cavin-1, controls the widening of TEMs, which rules out a role of caveolae membrane invaginations. This increase in both the number and width of TEMs correlates with a higher susceptibility of caveolin-1-deficient mice to the lethal effect of EDIN-B mART activity during <italic>S. aureus</italic> septicemia. Finally, using an independent biophysical technique and theoretical modeling, we provide compelling evidence that caveolin-1 contributes, independently of cavin-1, to increasing plasma membrane bending rigidity. These data point toward a role of cavin-1/caveolin-1 components of caveolae in the regulation of TEM nucleation through the modulation of membrane tension. Hence, we ascribe to caveolin-1 a function in stiffening the plasma membrane that is independent from cavin-1-dependent caveolae, which eventually modulates TEMs opening speed and width.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Caveolae control the density of TEM tunnels</title><p>The formation of large TEM tunnels is observed in endothelial cells intoxicated with EDIN-like factors from <italic>S. aureus</italic>, as well as with the prototypic exoenzyme C3 (ExoC3) from <italic>C. botulinum</italic>. Considering that RhoA inhibition increases endothelial cell spreading, we investigated the impact of ExoC3 treatment on the distribution and density of caveolae in the inner leaflet of the plasma membrane in human umbilical vein endothelial cells (HUVECs) (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). We used a cell unroofing approach that allows direct visualization of membrane invaginations on a platinum replica via transmission electron microscopy (<xref ref-type="bibr" rid="bib35">Lemerle et al., 2023</xref>). In both naïve and ExoC3-treated cells, we observed membrane-associated cytoskeleton filaments, the honeycomb structure of clathrin lattices, clathrin-coated pits, and rough aspects of pit-like caveolar invaginations (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We verified that the treatment of cells with ExoC3 had no impact on caveolin-1 and cavin-1 expression (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Of note, the density of the cytoskeletal filaments was less pronounced in the ExoC3-treated cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, arrowhead). Cells were transfected with a plasmid encoding GFP-caveolin-1 to confirm by immunogold labelling the presence of caveolin-1-positive caveolae invaginations at the ventral side of the plasma membrane (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). We quantified the density of caveolae in ExoC3-treated and control cells. In total, we analyzed an area <italic>A</italic><sub>area</sub> &gt; 175 µm<sup>2</sup> under each condition (n ≥ 16 membrane areas of independent cells per condition). We recorded a 1.6-fold decrease in the mean density of caveolae in the ExoC3-treated cells, which exhibited 3.4 ± 2.1 caveolae/µm<sup>2</sup> of membrane, compared to 5.4 ± 3.1 caveolae/µm<sup>2</sup> of membrane in untreated cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The pool of plasma membrane-located caveolae remaining in ExoC3-treated cells is evenly distributed with no detectable accumulation around TEM tunnels (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). ExoC3 treatment reduces the density of invaginated caveolae at the plasma membrane, pointing toward the interest of studying the impact of caveolae depletion in TEM formation.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>RhoA inhibition decreases the density of caveolae and actin stress fibers.</title><p>(<bold>A, B</bold>) Transmission electron micrographs show unroofed human umbilical vein endothelial cells (HUVECs) that were either left untreated (control) or treated with 100 μg/ml of ExoC3 (ExoC3) for 24 hr. Right panels show membrane areas at higher magnification with (i) invaginated caveolae (yellow arrowhead), (ii) clathrin-coated pits and patches (plain white arrowhead), (iii) actin filaments (empty white arrowhead), and (iv) transendothelial cell macroaperture (TEM) tunnels in ExoC3-treated cells (white star). Scale bars left panels: 1 µm for control and 5 µm for ExoC3 condition with 200 nm higher magnifications on right panels. (<bold>B</bold>) Yellow dots show immunogold-labeled GFP-CAV1. (<bold>C</bold>) Boxplot shows the density of caveolae per µm<sup>2</sup> of plasma determined on electron micrographs. Values analyzed with a mixed-effects linear model with random intercept and Tukey’s correction for pairwise comparison. *p=0.027 (n = 16 cells from three technical replicates). (<bold>D</bold>) Confocal spinning disk images show F-actin cytoskeleton of HUVECs left untreated (control) or treated with 100 μg/ml ExoC3 (ExoC3) overnight after 24 hr of transfection with siRNA control (siCTRL), targeting caveolin-1 (siCAV1) or cavin-1 (siPTRF). Cells were stained with phalloidin-TRITC. Arrowheads show stress fibers and stars show transcellular tunnels bounded by F-actin. Scale bars, 20 µm. (<bold>E</bold>) Histograms show the percentages of ExoC3-treated cells displaying at least one TEM (n = 1400 cells, eight independent experiments). Error bars show normal asymptotic 95% confidence intervals (CI). Data analysis with mixed-effect logistic regression model with correction for multiple comparisons using Tukey’s honestly significant difference (HSD) test. ****p&lt;0.0001, for both siCTRL vs. siCAV1 and siCTRL vs. siPTRF conditions with no difference between siCAV1 and siPTRF conditions.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig1">Figure 1C and E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Controls of siRNAs and RhoA ADP-ribosylation efficacies.</title><p>(<bold>A</bold>) Immunoblots show caveolin-1 (IB: CAV1) and cavin-1/PTRF (IB: PTRF) in total cellular extracts of human umbilical vein endothelial cells (HUVECs) transfected with siCTRL and then treated for 24 hr with ExoC3. Immunoblot GAPDH (IB: GAPDH) was used as the loading control. Immunoblots are representative of three independent experiments. (<bold>B</bold>) Immunoblots of caveolin-1 (IB: CAV1) and cavin-1/PTRF (IB: PTRF) show the specific and cross-depletion effects of siCAV1 and siPTRF. Immunoblot anti-GAPDH antibody (IB: GAPDH) shows equal loading. The graph shows caveolin-1 and cavin-1/PTRF levels normalized to the level of GAPDH (three independent experiments). (<bold>C</bold>) Western blots show the fraction of ADP-ribosylated RhoA in cells that were resistant to a second round of <italic>in vitro</italic> ADP-ribosylation with biotin-NAD+. Western blot shows the fraction of ADP-ribosylated RhoA <italic>in vitro</italic> as detected with streptavidin–peroxidase (IB: Biotin-ADPr), that is, not modified during cell intoxication. Immunoblotting with an anti-RhoA antibody (IB: RhoA) revealed equal RhoA protein levels. Immunoblotting with an anti-GAPDH antibody revealed equal protein loading. Blots are representative of n = 3 independent experiments. The graph shows the mean values of the blot signal intensities ± SDs. from n = 3 independent experiments. Values correspond to the signal intensities of biotin-tagged ADP-ribosylated RhoA (Biotin-ADPr) normalized to those of RhoA and GAPDH IB signals. Values are expressed as a percentage compared with the intensity of the siCTRL-transfected untreated cells, which was set to 100%.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Files with western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92078-fig1-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Data for western blot quantification in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B and C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig1-figsupp1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Caveolin-1 and cavin-1/PTRF depletion increases transendothelial cell macroaperture (TEM) formation in both ExoC3- and epidermal differentiation inhibitor (EDIN)-treated cells.</title><p>(<bold>A</bold>) The graph shows the distribution of human umbilical vein endothelial cells (HUVECs) between classes defined by TEM tunnel density ranging from a group of cells displaying only 1 TEM and those for which the density increased by a factor of 1 through those cells with 40 TEMs (y-axis). HUVECs were transfected with siCTRL, siCAV1, or siPTRF before treatment with ExoC3. The graph includes the geometric means (N<sub>TEM</sub>) of the density of TEMs per cell within the whole-cell population ± SD. Graph shows technical replicates pooled together. Statistical data analysis using a mixed-effect linear model, with random intercept showing significant differences between values of N<sub>TEM</sub>, ****p&lt;0.0001. Data from n = 1400 cells per condition from seven independent experiments. (<bold>B</bold>) Histograms show the percentages of EDIN-treated cells with at least one TEM (n = 986 cells per condition from five independent experiments). Error bars show 95% confidence intervals (CIs). Data analysis with a logistic regression model adjusted for multiple comparisons using Tukey’s honestly significant difference (HSD) test, ****p&lt;0.0001; the siCTRL vs. siCAV1 groups and the siCTRL vs. siPTRF groups. No difference was recorded between the siCAV1 and siPTRF groups. (<bold>C</bold>) The graph shows the distribution of HUVECs between classes as defined by TEM density with ranging from a group of cells displaying only 1 TEM and those for which the density increased by a factor of 1 through those cells with 40 TEMs (y-axis). HUVECs were transfected with siCTRL, siCAV1, or siPTRF before treatment with ExoC3. The graph includes values of the geometric means (N<sub>TEM</sub>) of the density of TEMs per cell within the whole-cell population ± SD. Statistical data analysis was based on a mixed linear model with a random intercept and fixed effects and revealed significant differences between N<sub>TEM</sub> values, ****p&lt;0.0001 (n &gt; 986 cells per condition from five independent experiments).</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig1-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Depletion of the caveolar accessory component EHD2 increases transendothelial cell macroaperture (TEM) formation.</title><p>(<bold>A</bold>) Immunoblots show EHD2 cellular levels (IB: EHD2) in total cellular extracts of human umbilical vein endothelial cells (HUVECs) transfected with siCTRL or siEHD2 and then treated for 24 hr with ExoC3. Immunoblot GAPDH (IB: GAPDH) was used as the loading control. Immunoblots are representative of n = 3 independent experiments. (<bold>B</bold>) Histograms show the percentages of C3-treated cells displaying at least one TEM (n = 1000 cells per condition from five independent experiments). Error bars show 95% confidence intervals (CIs). Data analysis with a logistic regression model adjusted for multiple comparisons using Tukey’s honestly significant difference (HSD) test, ****p&lt;0.0001 for the siCTRL vs. siEHD2 groups. (<bold>C</bold>) The graph shows the distribution of HUVECs between classes as defined by TEM density ranging from a group of cells displaying only 1 TEM and those for which the density increased by a factor of 1 through those cells with 40 TEMs/cell (y-axis). HUVECs were transfected with siCTRL or siEHD2 before treatment with ExoC3. The graph includes values of the geometric means (N<sub>TEM</sub>) of the density of TEMs per cell within the whole-cell population ± SD. Statistical data analysis was based on a mixed linear model with a random intercept and fixed effects and revealed significant differences between N<sub>TEM</sub> values, ****p&lt;0.0001 (n = 1000 cells per condition from five independent experiments).</p><p><supplementary-material id="fig1s3sdata1"><label>Figure 1—figure supplement 3—source data 1.</label><caption><title>Files with western blots.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92078-fig1-figsupp3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s3sdata2"><label>Figure 1—figure supplement 3—source data 2.</label><caption><title>Data for <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B and C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig1-figsupp3-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig1-figsupp3-v1.tif"/></fig></fig-group><p>Before functional analysis of the impact of caveolae components on TEM tunnel nucleation and growth, we analyzed the previously established stoichiometry of caveolin-1 and cavin-1 in response to siRNA treatments (<xref ref-type="bibr" rid="bib29">Hill et al., 2008</xref>). We observed that small interfering RNA (siRNA)-mediated depletion of caveolin-1 (siCAV1) strongly reduces both caveolin-1 and the cellular pool of cavin-1/PTRF by approximately 80% (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). In contrast, about one-half of the pool of caveolin-1 remained unaffected by the siRNA-targeted depletion of cavin-1/PTRF (siPRTF) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). We concluded that siPTRF leaves a cellular pool of caveolin-1 unaffected, contrary to siCAV1. Both siRNA treatments had no effect on the extent of mono-ADPribosylation of RhoA (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). We next quantified the efficiency of TEM tunnel formation in different conditions of siRNA treatment. HUVECs were treated with siCTRL, siCAV1, or siPTRF prior to ExoC3 treatment. Examples of cells treated in these conditions are shown in <xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="video" rid="video1">Videos 1</xref>–<xref ref-type="video" rid="video3">3</xref>. Quantitative measurements showed a higher percentage of cells displaying at least one TEM in the population of caveolin-1 or cavin-1-deficient cells (37.6 ± 1.3% siCAV1 and 36.4 ± 1.3% siPTRF vs. 28.8 ± 1.2% siCTRL) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Moreover, we observed a significant increase in the density of TEMs per cell in siCAV1 (N<sub>TEM_siCAV1</sub> = 1.96) and siPTRF (N<sub>TEM_siPTRF</sub> = 1.36) conditions compared to siCTRL (N<sub>siCTRL</sub> = 0.91) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). We verified that such an increase in TEM density per cell and within the cell population was also induced by the ExoC3-like RhoA-targeting mART EDIN from <italic>S. aureus</italic> (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B and C</xref>) or by siRNA-targeting EHD2 caveolae-stabilizing protein, a treatment that leaves caveolin-1 and cavin-1 unaffected (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). Together, these data show that the efficiency of the formation of TEMs is inversely correlated to the density and stability of caveolae at the plasma membrane.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-92078-video1.mp4" id="video1"><label>Video 1.</label><caption><title>Cycles of transendothelial cell macroaperture (TEM) tunnel opening and closure in GFP-LifeAct-expressing human umbilical vein endothelial cell (HUVEC) transfected with a control siRNA prior to intoxication with ExoC3 at 100 μg/ml for 24 hr.</title><p>Video recorded at one frame every 15 s and played at seven images per second. Scale bar, 10 μm.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-92078-video2.mp4" id="video2"><label>Video 2.</label><caption><title>Cycles of transendothelial cell macroaperture (TEM) tunnel opening and closure in GFP-LifeAct-expressing human umbilical vein endothelial cell (HUVEC) transfected with siRNA targeting caveolin-1 prior to intoxication with ExoC3 at 100 μg/ml for 24 hr.</title><p>Video recorded at one frame every 23 s and played at seven images per second. Scale bar, 10 μm.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-92078-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Cycles of transendothelial cell macroaperture (TEM) tunnel opening and closure in GFP-LifeAct-expressing human umbilical vein endothelial cell (HUVEC) transfected with siRNA targeting cavin-1 prior to intoxication with ExoC3 at 100 μg/ml for 24 hr.</title><p>Video recorded at one frame every 20.5 s and played at seven images per second. Scale bar, 10 μm.</p></caption></media></sec><sec id="s2-2"><title>Caveolae buffer the decrease in cell height triggered by RhoA inhibition-driven spreading</title><p>The formation of TEMs due to the disruption of RhoA-driven F-actin polymerization and actomyosin contraction is facilitated by a reduction in cell height that promotes contact between the apical and basal membranes (<xref ref-type="bibr" rid="bib48">Ng et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Tsai et al., 2022</xref>). We first quantified the mesh size of F-actin network using 2D stochastic optical reconstruction microscopy (STORM) that integrates F-actin signals with an ~30 nm resolution over the whole-cell thickness, which can be as thin as 50 nm at the cell periphery (<xref ref-type="bibr" rid="bib43">Maddugoda et al., 2011</xref>). The siCTRL, siCAV1, and siPTRF-transfected HUVECs displayed a classical organization of actin cytoskeleton with actin stress fibers intertwined with a high-density meshwork of F-actin (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, control). When siRNA-treated cells were next intoxicated with ExoC3, we observed the disruption of actin stress fibers together with a reorganization of the actin cytoskeleton into a loosely intertwined and irregular F-actin meshwork defining large zones devoid of F-actin (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, ExoC3). In all conditions of siRNA treatment, we have measured that ExoC3 treatment induces a significant increase in actin mesh size of about 0.2 μm<sup>2</sup> compared to non-intoxicated cells (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). No significant difference of mesh size was recorded between siCTRL, siCAV1, or siPTRF conditions before and after treatment with ExoC3 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Indeed, we observed in cells treated with ExoC3 no specific cellular pattern or bimodal distribution of mesh size between the different siRNA conditions but a rather very heterogeneous distribution of mesh size values that could reach a few square microns in all conditions. We concluded that in addition to the well-established impact of RhoA inhibition on actin stress fibers it generates a loose F-actin meshwork framing large cellular zones devoid of F-actin of same extent in all siRNA conditions.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>RhoA inhibition decreases F-actin mesh size with no significant effect of caveolae components.</title><p>(<bold>A</bold>) 2D stochastic optical reconstruction microscopy (STORM) images show the disruption of actin bundles and intertwined F-actin in cells intoxicated with ExoC3 at 100 μg/ml for 24 hr. Human umbilical vein endothelial cells (HUVECs) either left untreated or treated with ExoC3 before F-actin staining with phalloidin-AF647. Scale bar, 10 µm. High-magnification images are shown in the right panels. Scale bar, 1 µm. (<bold>B</bold>) Scatter dot plot shows the average mesh size per cell (µm²) of the F-actin network (black dots) overlaid with all individual values of mesh size (blue dots) shown in logarithmic scale. Quantification was performed with 2D STORM images of control (-) and ExoC3-treated cells (+) that were first treated with siCTRL (dark blue), siCAV1 (blue), and siPTRF (light blue). **p&lt;0.01, *p&lt;0.05 calculated with a nested <italic>t</italic>-test (n = 8–9 cells per group, three independent replicates).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig2-v1.tif"/></fig><p>We next investigated the role played by caveolin-1 and cavin-1 in the control of the cell height (<italic>h</italic>), an essential parameter in TEM nucleation. The mean value of this cell shape parameter is proportional to the ratio between the volume (<italic>V</italic>) and spreading area (<italic>A</italic>) of cells (<xref ref-type="table" rid="table1">Table 1</xref>). The spreading area was estimated from the measurement of cell contours (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The volume of cells was quantified by fluorescent dye exclusion, as depicted in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, and as previously described (<xref ref-type="bibr" rid="bib77">Zlotek-Zlotkiewicz et al., 2015</xref>). Upon intoxication of siCTRL-treated cells, we recorded a significant increase of 36% of the spreading area together with 17% increase of the cell volume (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref> and <xref ref-type="table" rid="table1">Table 1</xref>). The dominant impact of cell area changes over the volume parameter accounts for the calculated decrease of cell height of 15% (<xref ref-type="table" rid="table1">Table 1</xref>). Hence, when siCAV1- and siPTRF-transfected cells were treated with ExoC3, we recorded a reduction in cell volume concomitant to the increase in their spreading area (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref> and <xref ref-type="table" rid="table1">Table 1</xref>). The reinforced reduction in cell height recorded in siCAV1 or siPTRF-treated cells is in good agreement with our findings showing that these treatments increase the density of TEMs. Note that in the absence of ExoC3 we recorded that the effects of siPTRF on cell shape parameters were slightly stronger than those of siCAV1, thereby highlighting the key involvement of caveolae in the control of cell height (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>). The depletion of caveolae and the inhibition of RhoA work together to reduce cell height that favors together with the loss of F-actin the nucleation of TEMs.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Regulation of human umbilical vein endothelial cell (HUVEC) area and volume by cavin-1/PTRF, caveolin-1, and RhoA.</title><p>(<bold>A</bold>) Confocal spinning disk images of HUVECs stained with phalloidin-FITC and selected perimeters (yellow line) in the absence (- ExoC3) or presence of ExoC3 (+ExoC3). Stars show the presence of transendothelial cell macroaperture (TEM) in ExoC3-treated cells. Scale bar, 20 µm. (<bold>B</bold>) Schematic representation of the microfluidic chamber used to measure cell volume by fluorescence exclusion. Briefly, from the top (i) side view of the chamber in which a cell adheres to a coverslip. The PDMS pillar sustains the ceiling (gray), and the maximal height of the chamber <italic>h</italic><sub>max</sub> (background) is known. The siCTRL, siCAV1, or siPTRF-transfected HUVECs were seeded in the chamber and remained either untreated or treated with ExoC3. High molecular weight dextran-FITC (green) was added to the chamber and is nonpermeant to cells (values <italic>h</italic><sub>x,y</sub>); (ii) raw epifluorescence image showing a typical field of HUVEC; and (iii) the graph of fluorescence intensities (in grayscale) shows the function of distance along the dotted line. Parameters <italic>I</italic><sub>max</sub> and <italic>I</italic><sub>min</sub> yield values of maximum and minimum fluorescence intensities. Values for cell volume (<italic>V</italic><sub>cell</sub>) were obtained by integrating the fluorescence intensities <italic>h</italic><sub>max</sub> – <italic>h</italic><sub>x,y</sub> over the cell area. (<bold>C</bold>) Boxplots show the distribution of TEM area values estimated from measures of their perimeters, which is shown in (<bold>A</bold>). Measurements were performed with HUVEC transfected with siCTRL (dark blue), siCAV1 (blue), or siPTRF (light blue) and then treated with ExoC3 (+ExoC3) or untreated (- ExoC3). Measurements were performed with n &gt; 698 untreated cells and n &gt; 595 treated cells, five independent experiments. (<bold>D</bold>) Boxplots show the distribution of cell volumes, as described in (<bold>B</bold>). Measurements were performed on HUVEC transfected with siCTRL, siCAV1, or siPTRF and then treated with ExoC3 (+ExoC3) or untreated (-ExoC3). Data are from n = 216 and n = 308 cells after siCTRL ± ExoC3 treatment (dark blue), n = 197 and n = 266 cells after siCAV1 ± ExoC3 treatment (blue) and n = 152 and n = 157 cells after siPTRF 10 ± ExoC3 treatment (light blue); three independent experiments. The graphs show technical replicates pooled together. The data were analyzed with a mixed-effect generalized linear model with Gamma log-link function, random intercept accounting for technical variability, and Tukey’s correction for pairwise comparisons between control and each siRNA treatment, ****p&lt;0.0001, **p&lt;0.01, *p&lt;0.05 and ns, not significant.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig3">Figure 3C and D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig3-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Cell spreading area, volume, and height.</title><p>The means and standard deviations (SDs) of the cell spreading area (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) and volume (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Cell height was estimated by the ratio between the cell volume and cell area, and the SD was estimated via error propagation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Conditions</th><th align="left" valign="bottom">Mean cell area<italic>A</italic> (µm²)</th><th align="left" valign="bottom">SD of the cell area (µm²)</th><th align="left" valign="bottom">Mean cell volume<italic>V</italic> (µm<sup>3</sup>)</th><th align="left" valign="bottom">SD of the cell volume (µm<sup>3</sup>)</th><th align="left" valign="bottom">Cell height<italic>h</italic> (µm)</th><th align="left" valign="bottom">SD of the height (µm)</th></tr></thead><tbody><tr><td align="left" valign="bottom">siCTRL-</td><td align="char" char="." valign="bottom">6583</td><td align="char" char="." valign="bottom">5168</td><td align="char" char="." valign="bottom">2320</td><td align="char" char="." valign="bottom">3147</td><td align="char" char="." valign="bottom">0.35</td><td align="char" char="." valign="bottom">0.75</td></tr><tr><td align="left" valign="bottom">siCTRL+</td><td align="char" char="." valign="bottom">9025</td><td align="char" char="." valign="bottom">7258</td><td align="char" char="." valign="bottom">2710</td><td align="char" char="." valign="bottom">4326</td><td align="char" char="." valign="bottom">0.30</td><td align="char" char="." valign="bottom">0.72</td></tr><tr><td align="left" valign="bottom">siCAV1-</td><td align="char" char="." valign="bottom">7048</td><td align="char" char="." valign="bottom">5583</td><td align="char" char="." valign="bottom">2146</td><td align="char" char="." valign="bottom">3214</td><td align="char" char="." valign="bottom">0.30</td><td align="char" char="." valign="bottom">0.70</td></tr><tr><td align="left" valign="bottom">siCAV1+</td><td align="char" char="." valign="bottom">9831</td><td align="char" char="." valign="bottom">7984</td><td align="char" char="." valign="bottom">2357</td><td align="char" char="." valign="bottom">3010</td><td align="char" char="." valign="bottom">0.24</td><td align="char" char="." valign="bottom">0.50</td></tr><tr><td align="left" valign="bottom">siPTRF-</td><td align="char" char="." valign="bottom">7539</td><td align="char" char="." valign="bottom">5450</td><td align="char" char="." valign="bottom">1914</td><td align="char" char="." valign="bottom">2234</td><td align="char" char="." valign="bottom">0.25</td><td align="char" char="." valign="bottom">0.48</td></tr><tr><td align="left" valign="bottom">siPTRF+</td><td align="char" char="." valign="bottom">10,139</td><td align="char" char="." valign="bottom">7873</td><td align="char" char="." valign="bottom">2282</td><td align="char" char="." valign="bottom">2628</td><td align="char" char="." valign="bottom">0.23</td><td align="char" char="." valign="bottom">0.43</td></tr></tbody></table></table-wrap></sec><sec id="s2-3"><title>Caveolin-1 and cavin-1 have a different impact on TEM expansion dynamics</title><p>Since the TEM opening is transient, we next characterized the impact of caveolin-1 and cavin-1 in TEM dynamics, which allows us to define TEM maximal width. We implemented a pipeline of live-cell imaging and semi-automatic analysis that relies on the detection of LifeAct-GFP signal around TEMs to segment the opening area (<xref ref-type="bibr" rid="bib71">Tsai et al., 2022</xref>). <xref ref-type="fig" rid="fig4">Figure 4A</xref> shows the projections of the first image recorded for each TEM that formed over 1 hr recording (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We see that TEM tunnels preferentially open at the cell periphery where the cell height is minimal (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We then measured the maximal values of each TEM areas over 1 hr of video recording (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), as well as the speeds of opening and closure (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Interestingly, we recorded 5.4-fold wider TEMs in siCAV1-treated cells compared to siPTRF- and siCTRL-treatments (<xref ref-type="fig" rid="fig4">Figure 4B</xref> and <xref ref-type="video" rid="video1">Videos 1</xref>–<xref ref-type="video" rid="video3">3</xref>). Interestingly, the time for TEMs to reach their maximal diameter (<italic>t</italic><sub>max</sub>) and the overall TEM cycles (<italic>t</italic><sub>c</sub>) remains identical in all conditions (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Thus, TEMs became wider in siCAV1 condition in the absence of change in the time frame of opening, suggesting that caveolin-1 controls the speed of opening. To capture initial values of TEM opening speed (<italic>S</italic><sub>o</sub>), we used a 15-fold higher temporal resolution, that is, using a video recording of one image per second. Strikingly, we recorded a twofold higher opening speed in caveolin-1-depleted cells: <italic>S</italic><sub>o_siCAV1</sub> = 2.4 µm<sup>2</sup>/s versus <italic>S</italic><sub>o_siCTRL</sub> = 1.1 µm<sup>2</sup>/s in control cells, which contrasts with the minor impact of siPTRF with <italic>S</italic><sub>o_siPTRF</sub> = 1.7 µm<sup>2</sup>/s (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). In conclusion, we have identified a specific function of caveolin-1 in the regulation of the opening speed of TEMs that has a critical impact on TEM maximal width.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Caveolin-1 controls the transendothelial cell macroaperture (TEM) opening speed and maximum size.</title><p>(<bold>A</bold>) Images show examples of projections of all tunnels upon TEM initial opening (lower panel) in human umbilical vein endothelial cells (HUVECs) transfected with LifeAct-GFP expression plasmid and siCTRL, siCAV1, or siPTRF captured during 1 hr of live imaging. LifeAct-GFP HUVECs transfected with different siRNAs were treated with ExoC3 and recorded by live imaging for 1 hr. All initial TEM opening was based on the first frame in which TEM tunnels formed using ICY. The lower panel shows the projection of cumulative areas of initial TEM opening identified during 1 hr of live imaging. Scale bars, 20 µm. (<bold>B</bold>) Boxplot shows the distribution of TEMs, the maximal and median area values in HUVECs cotransfected with LifeAct-GFP-expressing plasmid and siCTRL, siCAV1, or siPTRF prior ExoC3 treatment. Maximal areas were determined based on each kinetic parameter of TEM dynamics, as shown in (<bold>C</bold>). The data represent n &gt; 105 TEMs in seven cells of each treatment group from &gt;3 independent experiments. Graph shows technical replicates pooled together. Statistical data analysis using a mixed-effect generalized linear model with Gamma log-link function, random intercept, and Tukey’s correction for multiple comparisons. ****p&lt;0.0001, **p&lt;0.01, and ns, nonsignificant. (<bold>C</bold>) The graph shows variations in TEM areas as a function of time expressed in minutes. HUVECs transfected with siCTRL, siCAV1, or siPTRF were treated with ExoC3 for 24 hr. The calculated values of <italic>t</italic><sub>max</sub> that corresponded to the time of opening to the time when the maximal areas were observed and the values of <italic>t</italic><sub>c</sub> corresponded to the time frame of a complete cycle of opening and closing are indicated on the graph for each condition. The data are from n &gt; 105 TEMs of seven cells per treatment from &gt;3 independent experiments. (<bold>D</bold>) Graph shows variations in mean values, expressed in seconds, in the TEM areas of cells treated with ExoC3. The curves were plotted with data obtained from time-lapse video recorded at one frame per second for 30 min. LifeAct-GFP-expressing cells transfected with siCTRL, siCAV1, and siPTRF. The data correspond to n &gt; 22 TEMs per condition from four independent experiments.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig4">Figure 4B–D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig4-v1.tif"/></fig></sec><sec id="s2-4"><title>Loss of caveolin-1 sensitizes mice to EDIN-B lethal effects during <italic>S. aureus</italic> sepsis</title><p>We reasoned that the increased density and width of TEMs triggered by the cellular depletion of caveolin-1 should result in higher susceptibility of caveolin-1-deficient (<italic>Cav1</italic>-/-) mice to the inhibition of RhoA by EDIN-like mART exotoxins during bloodstream infection by <italic>S. aureus</italic>. This would establish caveolin-1 as a resistance factor in the pathogenicity triggered by EDIN-like factors from <italic>S. aureus</italic>. To address this question, we first established the susceptibility of <italic>Cav1</italic>-/- mice and wildtype littermates (<italic>Cav1</italic>+/+) to <italic>S. aureus</italic> strain LUG1799 (WT <italic>edinB</italic>) in a model of septicemia (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). LUG1799 belongs to the European lineage ST80 derived from community-acquired methicillin-resistant <italic>S. aureus</italic>, which expresses EDIN-B mART exotoxin (EDIN-B) (<xref ref-type="bibr" rid="bib12">Courjon et al., 2015</xref>). We first monitored over a period of 7 d the survival of <italic>Cav1</italic>-/- and <italic>Cav1</italic>+/+ mice challenged with three increasing <italic>inocula</italic> of WT <italic>edinB</italic>. All the mice, except one <italic>Cav1</italic>-/- mouse, recovered from infection triggered with 5 × 10<sup>6</sup> CFU of bacteria/mouse (CFU/m), while all mice died 24 hr after intravenous injection of 5 × 10<sup>8</sup> CFU/m. In contrast, when mice were challenged with an intermediate dose of WT <italic>edinB</italic> of 5 × 10<sup>7</sup> CFU/m, we recorded a higher lethality of <italic>Cav1</italic>-/- compared to <italic>Cav1</italic>+/+mice (p&lt;0.001, Mantel‒Cox test). All the <italic>Cav1</italic>-/- mice died on day 1 post-challenge, whereas the death of <italic>Cav1</italic>+/+ occurred with a delay of 1–2 d, with one <italic>Cav1</italic>+/+ mouse surviving (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, 5 × 10<sup>7</sup> CFU/m). The loss of caveolin-1 expression thus sensitizes mice to bloodstream infection triggered by <italic>S. aureus</italic>-produced EDIN-B. We then explored the pathogenic effect of EDIN-B mART activity of RhoA. In control experiments with <italic>Cav1</italic>+/+ mice infected with either WT <italic>edinB</italic> or Δ<italic>edinB</italic> strains, we saw no difference of susceptibility between the strains and despite a broad range of four different <italic>inocula</italic> tested (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). In this set of experiments, we defined values of lethal dose 50 (LD<sub>50</sub>) at 2.5 × 10<sup>7</sup> CFU/m with both strains of <italic>S. aureus</italic>. When we challenged <italic>Cav1</italic>-/- mice with this LD<sub>50</sub> of <italic>S. aureus</italic> (2.5 × 10<sup>7</sup> CFU/m), we saw a lower survival with <italic>S. aureus</italic> WT <italic>edinB</italic> (n = 11 death/18 mice) compared to Δ<italic>edinB</italic> (n = 4 death/17 mice) (p=0.0123, Mantel‒Cox test) (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). To provide a causal link between the pathogenicity of EDIN-B recorded in <italic>Cav1</italic>-/- mice and the inhibition of RhoA catalyzed by EDIN-B, we performed a similar experiment with <italic>S. aureus</italic> Δ<italic>edinB</italic> complemented with a plasmid expressing either WT EDIN-B (Δ<italic>edinB</italic> pEDIN-B) or the catalytically inactive mutant EDIN-B-RE (Δ<italic>edinB</italic> pEDIN-B-RE). We saw a significant decrease in survival in caveolin-1-deficient mice infected with Δ<italic>edinB</italic> pEDIN-B compared to mice infected with Δ<italic>edinB</italic> pEDIN-B-RE. We concluded that in the context of bloodstream infection by <italic>S. aureus</italic>, caveolin-1 expression confers a resistance to the pathogenicity triggered by EDIN-B mART activity on RhoA.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Hyper-susceptibility of Cav1-deficient mice to EDIN-B mART activity on RhoA.</title><p>(<bold>A–D</bold>) Kaplan‒Meier survival curves over 7 d for <italic>Cav1</italic>-/- mice and/or <italic>Cav1</italic>+/+ littermates infected intravenously (i.v.) at day 0 with isogenic strains of <italic>Staphylococcus aureus</italic> and doses, expressed as colony-forming units per mouse (CFU/m). (<bold>A</bold>) Mice were challenged by intravenous injection of 5 × 10<sup>6</sup> CFU/mouse (group of 10 <italic>Cav1</italic>+/+ mice vs. group of 9 <italic>Cav1</italic>-/- mice), 5 × 10<sup>7</sup> CFU/mouse (group of 7 <italic>Cav1</italic>+/+ mice vs. group of 9 <italic>Cav1</italic>-/- mice) or 5 × 10<sup>8</sup> CFU/mouse (group of 7 <italic>Cav1</italic>+/+ mice vs. group of 8 <italic>Cav1</italic>-/- mice). Data show a significant increase in <italic>Cav1</italic>-/- lethality when challenged with 5 × 10<sup>7</sup> CFU/mouse. Log-rank test (Mantel‒Cox), p&lt;0.0011 at 5 × 10<sup>7</sup> CFU/mouse (n = 1 experiment). (<bold>B, C</bold>) Mouse lethal doses 50 (LD<sub>50</sub>) of WT <italic>edinB</italic> or Δ<italic>edinB</italic> strains established in <italic>Cav1</italic>+/+ mice (<bold>B</bold>) and <italic>Cav1</italic>-/- mice (<bold>C</bold>). (<bold>B</bold>) <italic>Cav1</italic>+/+ mice injected i.v. with 2.5 × 10<sup>7</sup> CFU/mouse (group of 12 mice for WT <italic>edinB</italic> and Δ<italic>edinB</italic> strains, n = 2 independent experiments). Log-rank test (Mantel‒Cox) shows no significant difference. (<bold>C</bold>) <italic>Cav1</italic>-/- mice were injected i.v. with 2.5 × 10<sup>7</sup> CFU/mouse (groups of 17 or 18 mice for WT <italic>edinB</italic> or Δ<italic>edinB</italic> strains, n = 2 independent experiments). Log-rank test (Mantel‒Cox) shows significant increase in susceptibility of <italic>Cav1</italic>-/- mice to WT <italic>edinB</italic> compared with Δ<italic>edinB</italic> (p=0.0123). (<bold>D</bold>) Comparative analysis of the susceptibility of <italic>Cav1</italic>-/- mice to bloodstream infection triggered by <italic>S. aureus</italic> Δ<italic>edinB</italic> complemented with a plasmid encoding wildtype EDIN-B (pEDIN-B) or the catalytically inactive EDIN-B mutant (pEDIN-B RE). Mice were injected with 2.5 × 10<sup>7</sup> CFU/mouse (groups of 20 CAV1<sup>-/-</sup> mice for Δ<italic>edinB</italic> pEDIN-B and for Δ<italic>edinB</italic> pEDIN-B RE strains, n = 2 independent experiments). Log-rank test (Mantel‒Cox) shows a higher susceptibility of <italic>Cav1</italic>-/- mice infected with <italic>S. aureus</italic> expressing catalytically active EDIN-B (p=0.0083).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title><italic>Cav1</italic>+/+ mice susceptibility to EDIN-B in staphylococcal septicemia.</title><p>Kaplan‒Meier survival curves with data obtained through 7 d from groups of <italic>Cav1</italic>+/+ infected intravenously at day 0 with different doses of LUG1799 wildtype <italic>S. aureus</italic>, expressed as colony-forming units per mouse (CFU/m). Comparative analysis of <italic>Cav1</italic>+/+ mouse susceptibility to bloodstream infection with either the WT <italic>edinB</italic> or Δ<italic>edinB</italic> strain. Mice were injected with 5 × 10<sup>6</sup> CFU/m (n = 5 mice infected with the WT <italic>edinB</italic> or Δ<italic>edinB</italic> strain; one experiment), 107 CFU/m (n = 17 and n = 19 mice infected with the WT <italic>edinB</italic> or Δ<italic>edinB</italic> strain, respectively; three experiments), 5 × 10<sup>7</sup> CFU/m (n = 19 or n = 18 mice infected with the WT <italic>edinB</italic> or Δ<italic>edinB</italic> strain; three experiments), and 5 × 10<sup>8</sup> CFU/m (n = 4 or n = 5 mice infected with either the WT or Δ<italic>edinB</italic> strain, respectively; one experiment). There were no significant differences in the kinetics of survival between the WT and Δ<italic>edinB-</italic>infected animals, as determined by log-rank test (Mantel‒Cox).</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig5-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Differential impacts of caveolin-1 and cavin-1 on membrane rigidity</title><p>Since we expect that <italic>S</italic><sub>o</sub> depends on membrane mechanical parameters (see the physical model description in ‘Materials and methods’), this suggests that caveolin-1, but not cavin-1, modulates TEM opening speed by affecting membrane mechanics. We then inferred changes in membrane mechanical properties upon depletion of caveolin-1 or cavin-1 using a refined theoretical model of cellular dewetting. This model accounts for the presence of several TEMs opening simultaneously (see the physical model description in ‘Materials and methods’). Importantly, the model is based on the hypothesis that plasma membrane deformation, enabling TEM nucleation and tunnel growth, is a function of membrane tension and bending rigidity, assuming a limited contribution of membrane adhesion to cortical cytoskeleton (<xref ref-type="bibr" rid="bib27">Helfrich, 1973</xref>). Indeed, consistent with this hypothesis of a minimal impact of cortical cytoskeleton elements on membrane mechanics, the 2D STORM images (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) established a massive disruption of the dense F-actin meshwork in ExoC3-treated cells, leaving large cellular zones devoid of F-actin. As explained in ‘Materials and methods’ in detail, the model predicts that the initial opening speed <italic>S</italic><sub>o</sub> is proportional to the membrane tension, consistent with a critical role of membrane tension in TEM growth (<xref ref-type="bibr" rid="bib24">Gonzalez-Rodriguez et al., 2020</xref>). From our measurements, we deduce that cells treated with siCAV1 have a significant twofold higher membrane tension than the controls, and no effect in siPTRF-treated cells (see ‘Materials and methods’). Moreover, according to the model, the maximum TEM size <italic>R</italic><sub>max</sub> depends strongly on membrane bending rigidity but weakly on the initial membrane tension. Thus, from our <italic>R</italic><sub>max</sub> measurements, the model allows the estimation of the bending rigidities <italic>κ</italic> in the different conditions. Using the following values for the siCTRL-treated cells – an initial membrane tension σ<italic><sub>0</sub></italic> = 2.5 10<sup>–5</sup> N/m (<xref ref-type="bibr" rid="bib56">Raucher and Sheetz, 2000</xref>) and a bending rigidity <italic>κ</italic><sub>siCTRL</sub> = 23.4 <italic>k</italic><sub>B</sub><italic>T</italic> (direct measurement, see below) – the model predicts a 55% reduction in membrane rigidity from a loss of expression of caveolin-1 and a lower reduction of 15% upon a loss of cavin-1 expression.</p><p>To test these predictions, we have treated cells with methyl-β-cyclodextrin to deplete cholesterol from the plasma membrane and reduce its bending rigidity (<xref ref-type="bibr" rid="bib68">Steinkühler et al., 2019</xref>); unfortunately, this treatment affected the cell morphology, which precluded further analysis. Therefore, we used an independent approach to measure the membrane bending rigidity in different conditions of cell treatment. This quantitative method is based on pulling membrane tethers from cell-derived plasma membrane spheres (PMSs) that are devoid of F-actin cortex and preserve the lipid membrane (<xref ref-type="fig" rid="fig6">Figure 6A</xref>; <xref ref-type="bibr" rid="bib64">Sinha et al., 2011</xref>; <xref ref-type="bibr" rid="bib7">Bo and Waugh, 1989</xref>; <xref ref-type="bibr" rid="bib38">Lingwood et al., 2008</xref>). PMSs prepared from untreated siCTRL-, siCAV1-, and siPTRF-treated HUVECs were aspirated into a micropipette, allowing to control membrane tension. Membrane tethers were pulled from PMSs using optical tweezers (<xref ref-type="bibr" rid="bib7">Bo and Waugh, 1989</xref>). The force, <italic>f</italic>, exerted on the membrane tether can be measured as a function of membrane tension (<italic>σ</italic>); it also depends on the bending rigidity (<italic>κ</italic>) following <inline-formula><mml:math id="inf1"><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mi>π</mml:mi><mml:msqrt><mml:mn>2</mml:mn><mml:mi>κ</mml:mi><mml:mi>σ</mml:mi></mml:msqrt></mml:math></inline-formula> (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>; <xref ref-type="bibr" rid="bib16">Derényi et al., 2002</xref>). We waited about 30 s after tube pulling and changing membrane tension and then checked that we reached a steady state, where lipids and membrane proteins had enough time to equilibrate (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). The analysis of the slope of <inline-formula><mml:math id="inf2"><mml:msup><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> versus <italic>σ</italic> provides a measurement of the membrane bending rigidity of a PMS (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). We measured a significant decrease of 30% of the bending rigidity from <italic>κ</italic><sub>siCTRL</sub> = 23.4 ± 0.9 <italic>k</italic><sub>B</sub><italic>T</italic> to <italic>κ</italic><sub>siCAV1</sub> = 17.0 ± 0.9 <italic>k</italic><sub>B</sub><italic>T</italic>. Moreover, we observed no significant difference in siPTRF conditions compared to siCTRL, with a <italic>κ</italic><sub>siPTRF</sub> = 23.4 ± 1.3 <italic>k</italic><sub>B</sub><italic>T</italic> (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). In good agreement with the theoretical predictions, these measurements establish that the expression of caveolin-1, but not of cavin-1, significantly stiffens the plasma membrane.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Caveolin-1 expression is a key determinant of membrane bending rigidity.</title><p>(<bold>A</bold>) Confocal spinning disk image of a human umbilical vein endothelial cell (HUVEC) displaying a calcein-AM-positive attached plasma membrane sphere (PMS) (arrowhead). Scale bar, 10 µm. (<bold>B</bold>) Schematic representation of the device used for measuring membrane mechanical parameters. It shows micropipette aspiration (gray) of a PMS (blue) and a tube pulled from the PMS through a bead bound to the PMS and trapped with an optical tweezer (purple). Increasing the aspiration pressure in the pipette allowed a progressive increase in the PMS membrane tension. (<bold>C</bold>) Confocal images show examples of calcein-AM-positive PMSs prepared from siCTRL-, siCAV1-, or siPTRF-transfected cells during micropipette aspiration. Scale bars, 2 µm. (<bold>D</bold>) The force required to pull membrane tubes rescaled to ((<italic>f</italic>–<italic>f</italic><sub>0</sub>)<sup>2</sup>/8π<sup>2</sup>) (in pN<sup>2</sup>), which is a function of the membrane tension (mN/m) for different siCTRL (dark blue), siCAV1 (blue), and siPTRF (light blue) treatments. The force <italic>f</italic><sub>0</sub> was measured for each tube as the force when the membrane tension vanishes. The bending rigidity <italic>κ</italic> (in <italic>k</italic><sub>B</sub><italic>T</italic>) was determined via the slope of the linear regression. The data were calculated from n = 5 to n = 10 tubes per condition (&gt;4 independent experiments). Linear regression data are shown as dashed lines, and 95% confidence intervals are shown as solid lines (slope ± SD). Data recorded between siCTRL and siCAV1 are significant showing no overlap between respective 95% confidence intervals.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Force measurements were done at equilibrium.</title><p>Graph shows an example of a force versus time curve during three consecutive tube-pulling experiments from the same plasma membrane sphere (PMS) (<xref ref-type="fig" rid="fig6">Figure 6</xref>). We observe that the force reaches equilibrium (plateau value) at about 10 s after the tube is pulled. After 30 s, the force remains constant, which means that we performed the tube-pulling experiments from the PMS under technical conditions of equilibrium, ensuring that lipids and membrane proteins had enough time to reach the tether by convective or diffusive movement.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Data for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-92078-fig6-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92078-fig6-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We report that siRNA-mediated knockdown of key structural and regulatory components of caveolae sensitizes endothelial cells to the formation of TEM tunnels triggered by the inhibition of RhoA-driven actomyosin contractility. Hence, inhibition of RhoA reduces by twofold the pool of caveolae invaginations at the plasma membrane. Mechanistically, we report that targeted depletion of caveolin-1 and cavin-1 caveolae decreases cell volume and increases cell spreading, which concur to decrease the height of cells favoring membrane apposition for TEM nucleation. Strikingly, we establish a specific role for caveolin-1 in controlling the opening speed of TEMs that has a dramatic impact on TEM size. In good agreement with the recorded increase in TEM formation and width following caveolin-1 knockdown, we establish a higher susceptibility of Cav1-deficient mice to lethal effects triggered by EDIN-B mART during staphylococcal bloodstream infection. Finally, we provide theoretical and experimental evidence that in addition to the well-established role of caveolae in membrane tension homeostasis, caveolin-1 rigidifies plasma membrane either directly or indirectly, as discussed below.</p><p>Our biophysical measurements unravel that caveolin-1 depletion decreases membrane bending rigidity by 30%, while depletion of cavin-1 has no impact. This experimental value is of the same order of magnitude as the 55% decrease in bending rigidity inferred from the cell dewetting model. The difference recorded between these approaches can be attributed to several approximations in the theoretical model, notably the simplified treatment of the physical membrane tension variation, the cytoskeletal contributions, and the interactions between neighboring TEM tunnels. Our tube-pulling experiments can be discussed along two lines. Indeed, since caveolin-1 is inserted in the cytosolic leaflet of the plasma membrane, when a nanotube is pulled toward the exterior of the PMS, we can expect two situations depending on the ability of caveolin-1 to deform membranes, which remains to be addressed (<xref ref-type="bibr" rid="bib55">Porta et al., 2022</xref>). (1) If Cav1 does not bend membranes, it could be recruited in the nanotube at a density similar to the PMS and our force measurement would reflect the bending rigidity of the PMS membrane. Cav1 could then stiffen membrane either as a stiff inclusion at high density or/and by affecting lipid composition. (2) If Cav1 bends the membrane, it is expected from caveolae geometry that the curvature in the tube would favor Cav1 exclusion. The force would then reflect the bending rigidity of the membrane depleted of Cav1, which should be the same in both types of experiments (WT and Cav1-depleted conditions) if the lipid composition remains unchanged upon Cav1 depletion. Note that the presence of a very reduced concentration of Cav1 compared to the plasma membrane has been reported in tunneling nanotubes (TNT) connecting two neighboring cells (<xref ref-type="bibr" rid="bib37">Li et al., 2022</xref>). The typical diameter of these TNTs is similar to the diameter of tubes pulled from PMS. At this stage, we cannot decipher between both properties for Cav1. Considering a direct mechanical role of Cav1, previous studies showed that inclusion of integral proteins in membranes had no impact on bending rigidity, as shown in the bacteriorhodopsin experiment (<xref ref-type="bibr" rid="bib44">Manneville et al., 1999</xref>), or even decreased membrane rigidity as reported for the Ca<sup>2+-</sup>ATPase SERCA (<xref ref-type="bibr" rid="bib22">Girard et al., 2005</xref>). Previous simulations have also confirmed the softening effect of protein inclusions (<xref ref-type="bibr" rid="bib20">Fowler et al., 2016</xref>). Nevertheless, our observations could be explained by a high density of stiff inclusions in the plasma membrane (&gt;&gt;10%), which is generally not achievable with the reconstituted membranes. Considering an impact on lipid composition, it is well established that caveolae are enriched with cholesterol, sphingomyelin, and glycosphingolipids, including gangliosides (<xref ref-type="bibr" rid="bib52">Parton et al., 2020b</xref>; <xref ref-type="bibr" rid="bib59">Roitenberg et al., 2018</xref>), which are known to rigidify membranes (<xref ref-type="bibr" rid="bib57">Rawicz et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Steinkühler et al., 2019</xref>). Thus, caveolin-1 might contribute to the enrichment of the plasma membrane with these lipid species. We did not establish experimental conditions allowing us to deplete cholesterol without compromising the shape of HUVECs, which prevented a proper analysis of TEM dynamics. Moreover, a previous attempt to increase TEMs width by softening the membrane through the incorporation of poly-unsaturated acyl chains into phospholipids failed, likely due to homeostatic adaptation of the membrane’s mechanical properties (<xref ref-type="bibr" rid="bib71">Tsai et al., 2022</xref>). Further studies are now required to establish whether and how caveolin-1 oligomers control membrane mechanical parameters through modulation of lipids organization or content. Caveolin-1 expression may also contribute to plasma membrane stiffening by interacting with membrane-associated components of the cortical cytoskeletal or structuring ordered lipid domains. Nevertheless, it has been reported that the Young’s modulus of the cell cortex dramatically decreases in ExoC3-treated cells (<xref ref-type="bibr" rid="bib48">Ng et al., 2017</xref>), suggesting a small additional contribution of caveolin-1 depletion to membrane softening. This is supported by 2D STORM data showing a dramatic reorganization of actin cytoskeleton in ExoC3-treated cells into a loose F-actin meshwork that is not significantly exacerbated by caveolin-1 depletion. Altogether, our results suggest that the presence of Cav1 stiffens plasma membranes, and that the exact origin of this effect must be further investigated.</p><p>Our study shows that membrane rigidity sets the maximal size of TEM aperture, although an actin ring appears before TEM closure (<xref ref-type="bibr" rid="bib67">Stefani et al., 2017</xref>). Actin ring assembly and stiffening is indeed a player in TEM opening, and it is included in our differential equation describing TEM opening dynamics (<xref ref-type="disp-formula" rid="equ3">Equation 3</xref>). In some configurations, actin ring assembly is the dominant player, such as in TEM opening after laser ablation (ex novo TEM opening), as we previously reported (<xref ref-type="bibr" rid="bib67">Stefani et al., 2017</xref>). In contrast, here we investigate de novo TEM opening, for which we expect that bending rigidity can be estimated without accounting for actin assembly (<xref ref-type="bibr" rid="bib23">Gonzalez-Rodriguez et al., 2012</xref>). Such a bending rigidity estimate (<xref ref-type="disp-formula" rid="equ5">Equation 5</xref>) is obtained by considering two different time scales: the time scale of membrane tension relaxation, governed by bending rigidity, and the time scale of cable assembly, governed by actin dynamics. We expect the first time scale to be shorter, and thus the maximum size of de novo TEMs to be mainly constrained by membrane tension relaxation. However, we cannot rule out that the formation of an actin cable around the TEM before it reaches its maximum size may limit the correct estimation of the bending rigidity.</p><p>Our data establish a function to cavin-1-dependent caveolae in the regulation of cell height. Indeed, we measured an increase in cell spreading and a decrease in cell volume upon depletion of caveolin-1 or cavin-1, which are essential components of caveolae. This is consistent with findings showing that cell homeostasis during spreading is achieved by decreasing cell volume. Such a coupling between variations in cell spreading area and cell volume is breached by disrupting cortical contractility, resulting in cell swelling (<xref ref-type="bibr" rid="bib73">Xie et al., 2018</xref>). Consistently, we show that the ExoC3-triggered increase in endothelial cell spreading occurs concomitantly with a decrease in cell volume. This might be a consequence of the inhibition of RhoA signaling, which is permissive for the activity of volume-regulated anion channels (<xref ref-type="bibr" rid="bib10">Carton et al., 2002</xref>). Here, we show that the decrease in cell volume upon depletion of cavin-1, and to a lesser extent after depletion of caveolin-1, occurs independently of RhoA signaling, that is, in ExoC3-treated cells. Thus, how caveolae control the cellular volume once RhoA signaling is inhibited awaits determination. Our findings also suggest that depletion of caveolae and RhoA inactivation may release membrane-folding-driven mechanical constraints that would limit cell spreading. Another hypothesis is that caveolae control indirectly the cellular geometry via a documented function of cavin-1 on cell signaling (<xref ref-type="bibr" rid="bib16">Derényi et al., 2002</xref>; <xref ref-type="bibr" rid="bib37">Li et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">Manneville et al., 1999</xref>; <xref ref-type="bibr" rid="bib22">Girard et al., 2005</xref>; <xref ref-type="bibr" rid="bib20">Fowler et al., 2016</xref>; <xref ref-type="bibr" rid="bib52">Parton et al., 2020b</xref>; <xref ref-type="bibr" rid="bib59">Roitenberg et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Rawicz et al., 2008</xref>; <xref ref-type="bibr" rid="bib73">Xie et al., 2018</xref>; <xref ref-type="bibr" rid="bib10">Carton et al., 2002</xref>; <xref ref-type="bibr" rid="bib31">Jansa et al., 2001</xref>; <xref ref-type="bibr" rid="bib30">Jansa and Grummt, 1999</xref>; <xref ref-type="bibr" rid="bib39">Liu and Pilch, 2016</xref>; <xref ref-type="bibr" rid="bib62">Shi et al., 2015</xref>).</p><p>Our study points to the underlying mechanisms by which caveolae regulate the frequency of TEM nucleation. Nucleation of TEMs requires the apposition of the basal and apical cell membranes, which is hindered by the intermembrane distance, set by the cell height. Meeting of the two membranes may create an initial precursor tunnel, which needs to be sufficiently big to enlarge into an observable TEM, instead of simply closing back. The size of the minimal precursor tunnel required to give rise to a TEM increases with membrane bending rigidity and decreases with membrane tension (<xref ref-type="bibr" rid="bib23">Gonzalez-Rodriguez et al., 2012</xref>). Silencing cavin-1 or caveolin-1 both lead to a decrease in cell height, thus favoring the likelihood of precursor tunnel nucleation. While silencing cavin-1 has no significant impact on either membrane tension or bending rigidity, silencing caveolin results in both an increase in membrane tension and a decrease in bending rigidity, which results in a decrease in the required minimal radius of the precursor tunnel, thus further favoring TEM nucleation. Overall, our results offer a consistent picture of the physical mechanisms by which caveolae modulate TEM nucleation.</p><p>The molecular basis of interindividual variability in <italic>S. aureus</italic> infections is unclear, although the expression of caveolin-1 has recently been suggested (<xref ref-type="bibr" rid="bib66">Spaan et al., 2022</xref>). Indeed, a human genetics study pinpointed the impact of haploinsufficiency of the OTULIN deubiquitinase in sensitizing host cells to lysis triggered by the highly prevalent α-hemolysin pore-forming toxin of <italic>S. aureus</italic>, a major determinant in staphylococcal pneumonia (<xref ref-type="bibr" rid="bib66">Spaan et al., 2022</xref>). The defect in OTULIN activity led to an increase in caveolin-1 cellular protein levels in dermal cells, which in turn upregulates the expression of the ADAM10 receptor of α-hemolysin pore-forming toxin. Here, we report that caveolin-1 expression is not regulated by RhoA signaling. Furthermore, we establish that the loss of caveolin-1 expression sensitizes mice to the lethal effects triggered by EDIN-B mART activity on RhoA during <italic>S. aureus</italic> septicemia, thus ascribing a pathogenicity potential to this exotoxin that is counteracted by the expression of caveolin-1. In line with this, a recent analysis of an observational cohort of patients with <italic>S. aureus</italic> community-acquired pneumonia indicated that EDIN-B, together with Panton–Valentin leukocidin, are positively associated with the etiology of hemoptysis, manifested by the presence of blood in sputum (<xref ref-type="bibr" rid="bib21">Gillet et al., 2021</xref>). Whether TEMs are involved in the etiology of hemoptysis remains to be investigated. Although we cannot argue that there is a causal link between the lethal effect of EDIN-B in caveolin-1-deficient animals and the protective function of caveolin-1 against TEM tunnel formation in endothelial cells, these findings represent a first step toward establishing that endothelial cells regulate TEM tunnel formation and width <italic>in vivo</italic>. Such a hypothesis is supported by previous findings showing that RhoA inhibition reduces paracellular permeability while dramatically increasing transcellular permeability, and that ADP-ribosyltransferases targeting RhoA increase vascular permeability to the point of animal death when TEM enlargement is no longer controlled (<xref ref-type="bibr" rid="bib8">Boyer et al., 2006</xref>; <xref ref-type="bibr" rid="bib60">Rolando et al., 2009</xref>). Collectively, these findings ascribe to variations in caveolin-1 expression a bidirectional impact on host susceptibility to <italic>S. aureus</italic> infection, pointing to a possible role of TEM tunnels.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Bacterial strains and culture conditions</title><p><italic>S. aureus</italic> HT20020209-LUG1799, referred to as wildtype WT <italic>edinB</italic> in this study, is a minimally passaged ST80 <italic>SCCmecIV</italic> PVL+ MRSA strain isolated in France (deposited at <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ena">http://www.ebi.ac.uk/ena</ext-link>) that is representative of ST80 CA-MRSA clones (<xref ref-type="bibr" rid="bib54">Perret et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Tristan et al., 2007</xref>). <italic>S. aureus</italic> HT20020209-LUG1799 with the <italic>edinB</italic> gene deletion is referred to as Δ<italic>edinB</italic> in this study (<xref ref-type="bibr" rid="bib12">Courjon et al., 2015</xref>). The strain Δ<italic>edinB</italic> was complemented with a pMK4-pPROT plasmid expressing the wildtype form of EDIN-B to generate the strain Δ<italic>edinB</italic> pEDIN-B or with pMK4-pPROT expressing the catalytically inactive mutant form of EDIN-B (EDIN-B-R185E) to generate the strain Δ<italic>edinB</italic> pEDIN-B RE, as previously described (<xref ref-type="bibr" rid="bib12">Courjon et al., 2015</xref>). Both strains were grown in lysogeny broth (LB) with shaking at 200 rpm and 37°C. Equal growth kinetics were verified (not shown).</p></sec><sec id="s4-2"><title>Mouse infection model</title><p>Adult male and female B6.Cg-<italic>Cav1<sup>tm1Mls</sup></italic>/J mice (strain # 007083, Jackson Laboratory) and C57BL/6J mice (Charles River) were housed under specific pathogen-free conditions at the Institut Pasteur animal facilities licensed by the French Ministry of Agriculture (B75150102). Mice received food and water ad libitum, and their weight was recorded daily throughout the study. <italic>S. aureus</italic> strains were cultured in LB at 37°C until reaching an OD<sub>600</sub> = 1 after overnight culture. After washing twice in PBS, cell pellets were resuspended in sterile 0.9% NaCl. Infections were carried out by injecting 300 µl serial dilutions of inoculum intravenously into the tail vein of the mice. Animal survival was monitored daily. The size of animal groups was calculated based on previous data and a power analysis assuming a risk of 5% and a power of 80%.</p></sec><sec id="s4-3"><title>Cell culture, transfection, and toxicity</title><p>Primary HUVECs (PromoCell) were cultured in human endothelial serum-free medium (SFM, Gibco) containing 20% fetal bovine serum, 20 ng/ml FGF-2, 10 ng/ml EGF, and 1 µg/ml heparin and referred to as complete SFM (SFMc). Cells were cultured on gelatine-coated culture ware at 37°C with 5% CO<sub>2</sub> for as many as six passages. For siRNA transfection, HUVECs were cultured at a density of 38,000 cells/cm<sup>2</sup>. ON-TARGETplus smart pool siRNA (Dharmacon) targeting human caveolin-1 (L-003467-00-0005), EHD2 (L-016660-00-0005), cavin-1/PTRF (L-012807-02-0005) or control RNAi SR-CL000 (Eurogentec) was used at 100 nM via magnetofection technology (OZ Biosciences) following the manufacturer’s instructions in serum-free OptiMEM (Gibco). When necessary, cells were electroporated 24 hr post-magnetofection and then used from 48 to 54 hr post-magnetofection. HUVEC electroporation of plasmids encoding caveolin-1-GFP (<xref ref-type="bibr" rid="bib64">Sinha et al., 2011</xref>) or LifeAct-GFP (ibidi, GmbH, Planegg/Martinsried, Germany) was performed as described in <xref ref-type="bibr" rid="bib18">Doye et al., 2002</xref>. Briefly, cells were trypsinized and resuspended in Ingenio Solution (Mirus) containing plasmid DNA (10 µg/10<sup>6</sup> cells) in a 4 mm cuvette (CellProjects). Cells were then electroporated at 300 V and 450 μF with one pulse of a GenePulser electroporator (Bio-Rad). Cells were incubated in SFMc, and the medium was replaced 3 hr post-electroporation. Cells were treated 6 hr post-electroporation. Recombinant ExoC3 and EDIN were produced in <italic>Escherichia coli</italic> and purified as described in <xref ref-type="bibr" rid="bib8">Boyer et al., 2006</xref>. Cells were treated with ExoC3 or EDIN exotoxins at a final concentration of 100 µM for 24 hr.</p></sec><sec id="s4-4"><title>Immunoblotting and western blotting</title><p>Proteins were resolved on 12% SDS-polyacrylamide gels and transferred to nitrocellulose membranes (GE Healthcare). The primary antibodies used were mouse anti-EHD2 (L-05) (Santa Cruz sc-100724), rabbit anti-Cav1 (Cell Signaling Technology #3238), rabbit anti-PTRF (Proteintech, 18892-1-AP), and mouse anti-GAPDH (Santa Cruz sc-47724). The secondary antibodies used were HRP-conjugated anti-mouse or anti-rabbit (Dako). Signals were imaged using an Imager-680 system from Amersham and were quantified with ImageJ software.</p></sec><sec id="s4-5"><title>Immunofluorescence</title><p>HUVECs were seeded on a gelatine-coated µ-Dish 35 mm, high (ibidi), and treated as indicated previously (<xref ref-type="bibr" rid="bib67">Stefani et al., 2017</xref>). Cells were fixed in ready-to-use paraformaldehyde (PFA), 4% in PBS (Bio-Rad). Immunostaining of fixed cells permeabilized in 0.5% Triton X-100 was performed. FITC-phalloidin or TRITC-phalloidin at 1 μg/ml (Sigma) were used to stain actin, and DAPI (Life Technologies) was used to label nuclei.</p></sec><sec id="s4-6"><title>Video microscopy</title><p>HUVECs were electroporated with LifeAct-GFP-pCMV as described above and seeded on a gelatine-coated polymer coverslip dish (ibidi). After treatment with ExoC3 (see above), the cells were supplemented with 25 mM HEPES (pH 7.4) and their proliferation was recorded at 37°C with a Nikon T<italic><sub>i</sub></italic> inverted microscope using an Ultraview spinning disk confocal system (PerkinElmer). For determining TEM opening, images were taken every 10–25 s for 1 hr. To determine the opening speed (<italic>S</italic><sub>o</sub>), images were taken every second for 30 min. Acquired videos were analyzed via an ICY-based semi-automatic protocol.</p></sec><sec id="s4-7"><title>Cell volume measurement</title><p>After siRNA treatment and other treatments, cells were seeded onto a PDMS chip (2.10<sup>6</sup> cells/ml) as described previously (<xref ref-type="bibr" rid="bib77">Zlotek-Zlotkiewicz et al., 2015</xref>). Briefly, chambers were coated with 10 µg/ml fibronectin in PBS (Life Technologies) for 1 hr at room temperature (RT). Chambers were washed with medium before cell seeding. Cells were resuspended in medium supplemented with 0.5 mg/ml Alexa Fluor 488 dextran (MW 10 kD; Life Technologies) and then injected into the chamber. Finally, the chamber was immersed in medium to prevent evaporation. HUVECs were allowed to adhere for 4–6 hr in SFMc at 37°C with 5% CO<sub>2</sub> before acquisition.</p><p>Images were analyzed with MATLAB (MathWorks). The intensity of the background was maximal in the absence of any object (<italic>I</italic><sub>max</sub>) and represented the fluorescence value for the maximal height of the chamber (<italic>h</italic><sub>max</sub>). In contrast, the pillar excludes fluorescence, which therefore reflects the minimal fluorescence intensity (<italic>I</italic><sub>min</sub>). At the cell level, the fluorescence was partially excluded at a given point for a cell at a given height (<italic>h</italic><sub>x,y</sub>). This strategy enables the measurement of the fluorescence intensity at this point (<italic>I</italic><sub>x,y</sub>). After calibrating the fluorescence intensity signal α = (<italic>I</italic><sub>max</sub> − <italic>I</italic><sub>min</sub>)/<italic>h</italic><sub>max</sub>, integration of the fluorescence intensity over the cell area provided the cell volume (<italic>V</italic><sub>cell</sub>).</p></sec><sec id="s4-8"><title>Metal replicates and transmission electron microscopy</title><p>Metal replicates of the ventral plasma membranes of HUVECs cultured on glass coverslips were obtained by sonication according to a published protocol (<xref ref-type="bibr" rid="bib35">Lemerle et al., 2023</xref>; <xref ref-type="bibr" rid="bib28">Heuser, 2000</xref>). Briefly, cells were rinsed three times with Ringer’s buffer with Ca<sup>2+</sup> and then briefly subjected to a concentration of 0.5 mg/ml poly-<sc>l</sc>-lysine diluted in Ca<sup>2+</sup>-free Ringer’s buffer (Sigma-Aldrich). Poly-<sc>l</sc>-lysine was removed by washing with Ca<sup>2+</sup>-free Ringer’s buffer. The coverslips were immersed in KHMgE buffer at 37°C before sonication (Vibra-Cell VCX130 ultrasonic processor, Sonics) at a 20% amplitude. The unroofed cell membranes were then immediately fixed for 30 min with 2% glutaraldehyde/2% PFA. The cell membranes were sequentially treated with 1% OsO<sub>4</sub>, 1.5% tannic acid, and 1% uranyl acetate before dehydration via successive ethanol baths, which was ultimately substituted with hexamethyldisilazane (#C16700-250; LFG Distribution).</p><p>For immunogold labeling, sonicated plasma membranes were fixed with 4% PFA before incubation with primary (GFP Thermo Fisher A11122 rabbit 1/20) and secondary antibodies coupled to gold beads (rabbit-gold 815.011 AURION goat 1/25), and the membranes were then incubated with a NaBH<sub>4</sub> solution to inactivate aldehydes. The membranes were finally fixed with 2% glutaraldehyde and subjected to the same treatment as that used for morphology studies. The dehydrated samples were metalized via rotary metallization. The coverslips were placed in the chamber of a metallizer (ACE600, Leica Microsystems). Once under a high vacuum (&gt;10<sup>–5</sup> mBar), the membranes were covered with 2 nm of platinum stabilized by 4–6 nm of braided carbon. The resulting platinum replicas were separated from the glass by flotation on acid, washed several times in distilled water baths containing 0.1% detergent (one drop in 10 ml, Photo-Flo, Kodak), and placed on electron microscopy (EM) grids covered with a carbon film (200 mesh formvar/carbon, LFG Distribution). The grids were mounted in the goniometer with eucentric side entry of a transmission electron microscope operating at 80 kV (CM120, Philips), and images were recorded with a Morada digital camera (Olympus). The images were processed with ImageJ software to adjust brightness and contrast and are presented in reverse contrast.</p></sec><sec id="s4-9"><title>RhoA mono-ADP-ribosylation assay</title><p>HUVECs were seeded at a density of 27,000 cells/cm<sup>2</sup> transfected with siCTRL, siCAV1, and siPTRF and then left untreated or treated with ExoC3. Cells were lysed in ADP-ribosylation buffer (20 mM Tris–HCl, 1  mM EDTA, 1 mM DTT, 5 mM MgCl<sub>2</sub> and cOmplete protease inhibitor EDTA-free [Roche], pH 7.5) and passed through a 27 G syringe 20 times. Cell lysates were collected by centrifugation at 12,000 × <italic>g</italic> for 10  min, and the protein concentration was determined by BCA assay (Thermo Fisher Scientific). The reaction was carried out by incubating 20 µg of cell lysate with 2 µg of ExoC3 and 10 µM 6-biotin-17-NAD<sup>+</sup> (BioLog) at 37°C for 30 min. The reaction was terminated by the addition of 1 mM DTT and Laemmli buffer (0.3 M Tris–HCl, 10% SDS, 37.5% glycerol, and 0.4 mM bromophenol blue) and boiling at 100°C for 5 min. The samples were subjected to 12% SDS‒PAGE, and the proportion of ADP-ribosylated (i.e., biotin-ADPr-RhoA) RhoA in the sample was measured by western blotting using streptavidin–peroxidase.</p></sec><sec id="s4-10"><title>Plasma membrane sphere formation and tether extraction</title><p>PMS were generated via a protocol adapted from <xref ref-type="bibr" rid="bib38">Lingwood et al., 2008</xref>. Cells were grown to 60–80% confluence on gelatine-coated 100 mm dishes and incubated for 6–8 hr in PMS buffer (1.5 mM CaCl<sub>2</sub>, 1.5 mM MgCl<sub>2</sub>, 5 mM HEPES, 2 mg/ml glucose, 150 mM NaCl, 10 μM MG132 in PBS [pH 7.4]) to induce membrane swelling of the PMSs. Individual PMSs were aspirated using a casein-passivated micropipette connected to a piezo-stage (PI, Karlsruhe, Germany) for manipulation and to a hydrostatic aspiration control system (<xref ref-type="bibr" rid="bib13">Cuvelier et al., 2005</xref>). Micropipettes were made in-house with borosilicate capillaries pulled into fine cones using a laser pipette puller (P-2000, Sutter Instrument Co.) and microforged at the desired inner diameter (3–4 µm), as described previously (<xref ref-type="bibr" rid="bib64">Sinha et al., 2011</xref>). For the extraction of tethers from PMSs, we used optical tweezers built in-house that consisted of a single fixed laser beam (infrared laser wavelength of 1070 nm) focused through a ×60 water objective mounted on a confocal microscope (Nikon TE2000 inverted microscope) (<xref ref-type="bibr" rid="bib65">Sorre et al., 2012</xref>). To pull tethers from PMSs, we coated streptavidin beads (3 µm in diameter, Spherotech) with fibronectin, which allowed the beads to bind to PMSs. A membrane tether was generated by bringing the micropipette-held PMS into contact with a bead trapped by the optical tweezers, and then by moving the PMS away from the bead. After extraction, the tether was held at a constant length between 2 and 5 μm, and tether forces were measured during gradual increase in aspiration pressure and thus PMS tension. At a given membrane tension, the corresponding tether force was measured at least 30 s after the pressure change and when equilibration was established (see representative force vs. time curve in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Analysis was performed as described below. Briefly, for each membrane tether, the tether force (<italic>f</italic>) was plotted as a function of the square root of the membrane tension (<italic>√</italic>σ) calculated using the Laplace law (<xref ref-type="bibr" rid="bib19">Evans and Rawicz, 1990</xref>) and corrected when the length of the ‘tongue’ of a PMS tether inside the micropipette was shorter than the radius of the pipette (<xref ref-type="bibr" rid="bib25">Guevorkian et al., 2021</xref>). For each tether, we determined a force <italic>f<sub>0</sub></italic> corresponding to the intercept of the linear regression (<italic>f</italic> vs. <italic>√</italic>σ). To estimate the bending rigidity for PMSs obtained from membranes of cell treated differently (siCRTL, siCAV1, and siPTRF cells), the data obtained for all tethers were pooled and rescaled as (<italic>f-f</italic><sub>0</sub>)²/8π² and plotted as a function of membrane tension. The corresponding PMS rigidity was obtained from the slope of the linear fit calculated using GraphPad Prism.</p></sec><sec id="s4-11"><title>Single-molecule localization microscopy of F-actin</title><p>For single-molecule localization microscopy (SMLM) of F-actin, we used 2D STORM. HUVECs were cultured on 1.5 high-performance coverslips coated with 10 µg/ml fibronectin for 2 hr at RT. Soluble G-actin was pre-extracted (0.25% Triton, 0.1% glutaraldehyde in 80 mM PIPES, 5 mM EGTA, and 2 mM MgCl<sub>2</sub>, pH 6.8) for 30 s at 37°C. The cells were then treated with glutaraldehyde (0.25% Triton, 0.5% glutaraldehyde in 80 mM PIPES, 5 mM EGTA, 2 mM MgCl<sub>2</sub>, pH 6.8) for 10 min at 37°C. Glutaraldehyde was quenched for 7 min at RT (0.1% NaBH<sub>4</sub> in PBS). Saturation was reached after 1 hr at RT (0.22% gelatine and 0.1% Triton X-100 in PBS, pH 7.3). Actin filaments were stained overnight at 4°C with phalloidin-AF647 (500 nM in PBS). Cells were then placed in switching buffer freshly prepared before imaging (50 mM Tris, 10 mM NaCl, 10% glucose, 0.5 mg/ml glucose oxidase, 50 µg/ml catalase, and 50–100 mM cysteamine [MEA, pH 8.3]) in the presence of phalloidin A647 (10–50 nM). Super-resolved images were acquired with an Elyra-7 SMLM microscope (Carl Zeiss, Germany) using an N.A = 1.4 oil ×63 objective (Carl Zeiss) with 1.518 refractive index oil (Carl Zeiss) and a pco.edge 4.2 camera system (Excelitas PCO GmbH). All processing analyses were performed with Zen software (Carl Zeiss). Localization of individual molecules was determined using a peak mask size of 15-pixel diameter and a peak intensity-to-noise ratio between 5 and 6. Drift was corrected using a model-based algorithm from Zen software. Super-resolution images were reconstructed at a 20 nm pixel size.</p></sec><sec id="s4-12"><title>Mesh analysis of the F-actin network imaged via 2D STORM</title><p>To quantify actin mesh size from the super-resolution images, we developed an image analysis workflow to reliably segment the delimiting continuous actin filaments. First, we clipped the images to a maximum detection count of 10 and applied a line enhancement filter to suppress short apparent discontinuities by modifying a previously described approach (<xref ref-type="bibr" rid="bib3">Al Jord et al., 2022</xref>). Specifically, the maxima of the mean intensities along line profiles at 15 equally spaced orientations around each pixel were calculated (line length 21 px or approximately 0.4 µm). Subsequently, tube-like structures were extracted from the line-enhanced images by applying a Hessian filter implemented in scikit-image (smoothing width of 2 px) as described previously (<xref ref-type="bibr" rid="bib72">van der Walt et al., 2014</xref>) with results binarized using Otsu thresholding. The obtained masks were subdivided into putative filament segments by defining sections of equal length along the mask’s morphological skeleton and assigning each pixel to its nearest segment (the chosen length was 20 px or approximately 0.4 µm). The final actin filament segmentation was performed considering only segments that (1) were not morphologically connected to at least one other segment, to exclude non-filament detections, or (2) exhibited a mean detection count lower than the super-resolution image Otsu threshold. Finally, the actin meshwork was obtained as the connected components of the inverted actin filament segmentation mask.</p></sec><sec id="s4-13"><title>Physical modeling</title><p>TEM dynamics were theoretically interpreted based on the generalization of our earlier model, which was used for a single TEM (<xref ref-type="bibr" rid="bib23">Gonzalez-Rodriguez et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Stefani et al., 2017</xref>), to account for the case when several TEMs open simultaneously. This generalization was previously used to interpret the data in <xref ref-type="bibr" rid="bib71">Tsai et al., 2022</xref>, and we present it here for completeness. The opening of a TEM is driven by a net force,<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mi>σ</mml:mi><mml:mo>−</mml:mo><mml:mfrac><mml:mi>T</mml:mi><mml:mi>R</mml:mi></mml:mfrac><mml:mo>,</mml:mo></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where σ is the membrane tension, <italic>T</italic> is the line tension, and <italic>R</italic> is the TEM radius. For a model lipid membrane in the entropic regime, membrane tension <italic>σ</italic> depends on <italic>R</italic>, quantified by the Helfrich’s law. Written in a generalized form to describe <italic>N</italic> simultaneous TEMs in the same cell, Helfrich’s law states that<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>σ</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>8</mml:mn><mml:mi>π</mml:mi><mml:mi>κ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> , <italic>R</italic><sub>cell</sub> is the radius of the cell, <italic>k</italic><sub>B</sub> is the Boltzmann constant, <inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> is the temperature, and <italic>κ</italic> is the effective bending rigidity of the cell membrane, which quantifies the energy required to bend the membrane. <xref ref-type="disp-formula" rid="equ2">Equation 2</xref> treats the effect of several simultaneous TEMs in an additive manner. This approximation is used here to predict TEM size because at maximum opening of simultaneous TEMs their respective membrane relaxation is felt by each other as it can be inferred from the shape that neighboring TEMs adopt in experiments. This additive treatment would appear less appropriate to describe the likelihood of nucleating a second TEM in the presence of a first one (a calculation that is not performed here) since membrane relaxation by a TEM may not be felt at membrane regions distant from it. While rigorously derived for a pure lipid membrane, we assumed that Helfrich’s law is applicable to describe the relationship between the effective membrane tension <inline-formula><mml:math id="inf5"><mml:mi>σ</mml:mi></mml:math></inline-formula> acting on TEMs and the observed projected surface in our cells. We expect Helfrich’s law to be applicable on short time scales, before active cell tension regulation takes place (<xref ref-type="bibr" rid="bib61">Sens and Plastino, 2015</xref>), especially in cases where cytoskeletal forces play a modest role, such as for red blood cells (<xref ref-type="bibr" rid="bib27">Helfrich, 1973</xref>) or for the highly disrupted cytoskeletal structure of our intoxicated cells. Thus, the parameter <inline-formula><mml:math id="inf6"><mml:mi>κ</mml:mi></mml:math></inline-formula> in <xref ref-type="disp-formula" rid="equ2">Equation 2</xref> is an <italic>effective</italic> bending rigidity, whose value may somewhat differ from that of a pure lipid membrane to account for the role played by protein inclusions and the mechanical contribution of the remaining cytoskeletal elements after cell treatment with the toxin. Moreover, we assumed that an eventual buffering role played by the remaining caveolae can be described through modification of the effective parameters <inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and <italic>κ</italic>. A limitation of our theoretical description arises from the use of spatially uniform changes in parameter values to describe the differences between experimental conditions, thus assuming spatially uniform effects. However, we cannot exclude the existence of nonuniform effects, such as changes in the size and organization of the remaining actin mesh, which could set local, nonuniform barriers to TEM enlargement in a manner not accounted for by our model.</p><p>As discussed by <xref ref-type="bibr" rid="bib23">Gonzalez-Rodriguez et al., 2012</xref>, the effective line tension is not a constant; it increases with time due to the formation of an actomyosin cable around the TEM. Stefani et al. described this increase as linear, <italic>T</italic> ~ <italic>αt</italic>. The dynamics of TEM opening are derived from a balance between the driving force (<xref ref-type="disp-formula" rid="equ2">Equation 2</xref>) and cell–substrate friction. Assuming <italic>N</italic> identical TEMs, this balance is<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mn>2</mml:mn><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>R</mml:mi><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:msup><mml:mi>R</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mi>α</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:msup><mml:mi>R</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <italic>μ</italic> is the friction coefficient. While this equation can be solved numerically, the following analytical approximation can also be obtained, as derived in <xref ref-type="bibr" rid="bib71">Tsai et al., 2022</xref>:<disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>x</mml:mi><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>x</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo>≈</mml:mo><mml:mfrac><mml:mrow><mml:mn>8</mml:mn><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msqrt><mml:mi>N</mml:mi></mml:msqrt></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mi>α</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <italic>x</italic> = <italic>N</italic><sup>1/2</sup> <italic>R</italic><sub>max</sub>/<italic>R<sub>c</sub></italic> and <italic>R</italic><sub>max</sub> is the maximum TEM radius. As discussed in <xref ref-type="bibr" rid="bib71">Tsai et al., 2022</xref>, for biologically relevant values of the model parameters, <xref ref-type="disp-formula" rid="equ4">Equation 4</xref> leads to the following approximate estimate of the effective membrane bending rigidity:<disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>κ</mml:mi><mml:mo>≈</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mrow><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mn>8</mml:mn><mml:mi>π</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mi>N</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>Considering the experimental results shown in <xref ref-type="table" rid="table2">Table 2</xref> and using the estimate <italic>κ</italic> ~ (<italic>N</italic>·<italic>A</italic><sub>max</sub>) <sup>-1</sup> based on <xref ref-type="disp-formula" rid="equ5">Equation 5</xref>, we deduced an effective bending rigidity decrease after silencing caveolin-1. We note that the estimate of <italic>κ</italic> provided by <xref ref-type="disp-formula" rid="equ5">Equation 5</xref> is independent of <italic>α</italic> and thus of actin cable assembly. This simplification arises from membrane tension relaxing over a shorter time scale than actin assembly. Thus, we expect the maximum size of de novo TEMs to be mainly constrained by membrane tension relaxation (<xref ref-type="bibr" rid="bib23">Gonzalez-Rodriguez et al., 2012</xref>), unlike ex novo TEM enlargement upon laser ablation, for which the dynamics of actin cable assembly control TEM opening (<xref ref-type="bibr" rid="bib67">Stefani et al., 2017</xref>). The approximate estimates given in <xref ref-type="table" rid="table2">Table 2</xref> can be refined using <xref ref-type="disp-formula" rid="equ4">Equation 4</xref> directly, which also considers variations in membrane tension. The following expression for the bending rigidity is thus obtained:<disp-formula id="equ6"><label>(6)</label><mml:math id="m6"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>κ</mml:mi><mml:mo>≈</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mrow><mml:mover><mml:mi>T</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mn>8</mml:mn><mml:mi>π</mml:mi></mml:mrow></mml:mfrac><mml:mfrac><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mi>N</mml:mi><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mn>8</mml:mn><mml:msubsup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mi>μ</mml:mi><mml:mi>α</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mstyle></mml:mrow></mml:math></disp-formula></p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Estimate of the variation of mechanical cell parameters between different experimental conditions.</title><p>The value of the effective membrane tension <italic>σ</italic><sub>0</sub> for the control case is obtained from earlier estimates (<xref ref-type="bibr" rid="bib18">Doye et al., 2002</xref>). The increase in <italic>σ</italic><sub>0</sub> for siCAV1 and siPTRF cell membranes is deduced from our experimental data using <xref ref-type="disp-formula" rid="equ9">Equation 9</xref>. The transendothelial cell macroaperture (TEM) maximum area, <italic>A</italic><sub>max</sub>, is the median not the average value because the median is a more robust estimator in the presence of a few extremely large values. As discussed in the text, the variations in the bending rigidity are roughly proportional to variations in (<italic>N</italic> · <italic>A</italic><sub>max</sub>)<sup>–1</sup>, where <italic>N</italic> is the average number of TEMs opening simultaneously and <italic>A</italic><sub>max</sub> is the TEM maximum area.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Condition</th><th align="left" valign="bottom"><italic>σ</italic><sub>0</sub> (μN/m)</th><th align="left" valign="bottom"><italic>A</italic><sub>max</sub> (μm<sup>2</sup>)</th><th align="left" valign="bottom"><italic>N</italic> (average)</th><th align="left" valign="bottom">(<italic>N</italic> · <italic>A</italic><sub>max</sub>)<sup>–1</sup> (μm<sup>–2</sup>)</th></tr></thead><tbody><tr><td align="left" valign="bottom">Control</td><td align="char" char="plusmn" valign="bottom">25 ± 10</td><td align="char" char="plusmn" valign="bottom">8.1 ± 0.5</td><td align="char" char="plusmn" valign="bottom">0.90 ± 0.09</td><td align="char" char="plusmn" valign="bottom">0.137 ± 0.022</td></tr><tr><td align="left" valign="bottom">siCAV1</td><td align="char" char="plusmn" valign="bottom">50 ± 7</td><td align="char" char="plusmn" valign="bottom">23 ± 4</td><td align="char" char="plusmn" valign="bottom">1.92 ± 0.15</td><td align="char" char="plusmn" valign="bottom">0.023 ± 0.006</td></tr><tr><td align="left" valign="bottom">siPTRF</td><td align="char" char="plusmn" valign="bottom">29 ± 7</td><td align="char" char="plusmn" valign="bottom">9.3 ± 0.7</td><td align="char" char="plusmn" valign="bottom">1.34 ± 0.11</td><td align="char" char="plusmn" valign="bottom">0.080 ± 0.012</td></tr></tbody></table></table-wrap><p><xref ref-type="disp-formula" rid="equ6">Equation 6</xref> is used to obtain the predictions of bending rigidity variations mentioned in the text: a reduction in effective bending rigidity by a factor of approximately 1.2 for siPTRF cell membranes and by a factor of approximately 2.3 for siCAV1 cell membranes, which is equivalent to a 15% decrease for siPTRF and 55% for siCAV1 cell membranes.</p></sec><sec id="s4-14"><title>Fit of the initial opening speed</title><p>For short time intervals, the differential equation for the opening dynamics can be simplified to<disp-formula id="equ7"><label>(7)</label><mml:math id="m7"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>μ</mml:mi><mml:msup><mml:mi>R</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mfrac><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi>R</mml:mi></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <italic>R<sub>n</sub></italic> =<italic>T</italic>/(2<italic>σ</italic><sub>0</sub>) is the minimal nucleation radius. This equation can be integrated to obtain<disp-formula id="equ8"><label>(8)</label><mml:math id="m8"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mi>R</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mfrac><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi>R</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:msup><mml:mi>R</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mn>2</mml:mn></mml:mfrac><mml:mo>−</mml:mo><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mi>μ</mml:mi></mml:mfrac><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <italic>C</italic> is an integration constant, whose value is such that <inline-formula><mml:math id="inf8"><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> for <inline-formula><mml:math id="inf9"><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula>, with <italic>R</italic><sub>0</sub> the unknown nucleated TEM radius, which is larger than the minimal nucleation radius <italic>R<sub>n</sub>; R</italic><sub>0</sub> &gt; <italic>R<sub>n</sub></italic>. Because all TEM measurements reflect <inline-formula><mml:math id="inf10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>R</mml:mi><mml:mo>≫</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> , the dominant term on the left-hand side is the term proportional to <inline-formula><mml:math id="inf11"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mo>/</mml:mo><mml:mi>π</mml:mi></mml:math></inline-formula>, where <italic>A</italic> is the TEM area. These considerations yield the following estimate of σ<sub>0</sub>:<disp-formula id="equ9"><label>(9)</label><mml:math id="m9"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mi>μ</mml:mi></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>4</mml:mn><mml:mi>π</mml:mi><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where Δ<italic>t</italic> = 1 s is the time interval between two acquisitions; <italic>A</italic><sub>1</sub> is the TEM area in the first image after TEM opening (taken on average at a time Δ<italic>t</italic>/2), and <italic>A</italic><sub>2</sub> is the TEM area in the second image.</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>Statistical tests were performed using the R Software v4.2.1 (R Foundation for Statistical Computing, Vienna, Austria; <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>), along with packages lme4 (1.1–30) (<xref ref-type="bibr" rid="bib6">Bates et al., 2015</xref>), lmerTest (v3.1–3) (<xref ref-type="bibr" rid="bib33">Kuznetsova et al., 2017</xref>), emmeans (v1.8.0), except for the F-actin mesh size where the Prism Software was used. All experiments were repeated at least three times to ensure reproducibility and corresponding variability was accounted for in statistical analyses using mixed-effect regressions, with a random intercept estimated for every technical replicate. In particular, binomial outcomes (e.g., presence/absence) were analyzed using mixed-effect logistic regression. Continuous measurements (e.g., TEM area) were investigated with a Gamma log-link function in a mixed-effect framework. Contrasts between multiple pairs of categorical predictors were calculated through estimated marginal means with Tukey’s correction. p-Values were calculated as indicated in the respective figure legends. p-Values were considered statistically significant at p≤0.05. Significance levels are indicated as follows: ns: not significant if p&gt;0.05; *p≤0.05; **p≤0.01; ***:p≤0.001; ****p≤0.0001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Software, Investigation, Methodology, Writing – review and editing, Statistical analysis</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Methodology</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con9"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Resources</p></fn><fn fn-type="con" id="con11"><p>Resources</p></fn><fn fn-type="con" id="con12"><p>Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con14"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Data curation, Formal analysis, Supervision, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Supervision, Methodology, Writing – original draft, Writing – review and editing, Theoretical modeling</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Formal analysis, Supervision, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con18"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Adult male and female B6.Cg-Cav1tm1Mls/J mice (strain #: 007083, Jackson Laboratories) and C57BL/6J mice (Charles River) were housed under specific-pathogen-free conditions at the Institut Pasteur animal facilities licensed by the French Ministry of Agriculture (B75150102).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92078-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>C Morel and E Lemerle were supported by PhD fellowships from the University Paris Cité Doctoral School BioSPC and Sorbonne University Doctoral School complexité du vivant, respectively. We thank Marie Anne Nahori, Amel Mettouchi, Arnaud Echard, Virginia Ribeiro de Andrade (Institut Pasteur, Paris, France), and Michael Henderson (Institut Pasteur/Institut Curie, Paris France) for technical advice, sharing reagents, and discussions. We thank Pierre Nassoy (LP2N, Bordeaux, France), Francoise Brochard Wyart (Institut Curie, Paris, France), and Anne Blangy (CRBM, CNRS, Montpellier, France) for insightful discussions. We thank Darius Koster for sharing results and fruitful discussions on tether pulling experiments of plasma membrane spheres. We thank Gaëlle Letort (Department of Developmental and Stem Cell Biology, Institut Pasteur, CNRS UMR 3738) for helpful advice on image analysis. We also thank the UTechS PBI, which is part of the France–BioImaging infrastructure network (FBI) supported by the French National Research Agency (ANR-10-INBS-04; Investments for the Future) and acknowledge support from Institut Pasteur, ANR/FBI, the Région Ile-de-France (program DIM1HEALTH), and the French Government Investissement d'Avenir Programme-Laboratoire d'Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (ANR-10-LABX-62-IBEID) for the use of the Zeiss ELYRA7 microscope.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aird</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2007">2007a</year><article-title>Phenotypic heterogeneity of the endothelium: II. Representative vascular beds</article-title><source>Circulation Research</source><volume>100</volume><fpage>174</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000255690.03436.ae</pub-id><pub-id pub-id-type="pmid">17272819</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aird</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2007">2007b</year><article-title>Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms</article-title><source>Circulation Research</source><volume>100</volume><fpage>158</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000255691.76142.4a</pub-id><pub-id pub-id-type="pmid">17272818</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Jord</surname><given-names>A</given-names></name><name><surname>Letort</surname><given-names>G</given-names></name><name><surname>Chanet</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>F-C</given-names></name><name><surname>Antoniewski</surname><given-names>C</given-names></name><name><surname>Eichmuller</surname><given-names>A</given-names></name><name><surname>Da Silva</surname><given-names>C</given-names></name><name><surname>Huynh</surname><given-names>J-R</given-names></name><name><surname>Gov</surname><given-names>NS</given-names></name><name><surname>Voituriez</surname><given-names>R</given-names></name><name><surname>Terret</surname><given-names>M-É</given-names></name><name><surname>Verlhac</surname><given-names>M-H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cytoplasmic forces functionally reorganize nuclear condensates in oocytes</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>5070</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-32675-5</pub-id><pub-id pub-id-type="pmid">36038550</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariotti</surname><given-names>N</given-names></name><name><surname>Rae</surname><given-names>J</given-names></name><name><surname>Leneva</surname><given-names>N</given-names></name><name><surname>Ferguson</surname><given-names>C</given-names></name><name><surname>Loo</surname><given-names>D</given-names></name><name><surname>Okano</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>MM</given-names></name><name><surname>Walser</surname><given-names>P</given-names></name><name><surname>Collins</surname><given-names>BM</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular characterization of caveolin-induced membrane curvature</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>24875</fpage><lpage>24890</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.644336</pub-id><pub-id pub-id-type="pmid">26304117</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barzilai</surname><given-names>S</given-names></name><name><surname>Yadav</surname><given-names>SK</given-names></name><name><surname>Morrell</surname><given-names>S</given-names></name><name><surname>Roncato</surname><given-names>F</given-names></name><name><surname>Klein</surname><given-names>E</given-names></name><name><surname>Stoler-Barak</surname><given-names>L</given-names></name><name><surname>Golani</surname><given-names>O</given-names></name><name><surname>Feigelson</surname><given-names>SW</given-names></name><name><surname>Zemel</surname><given-names>A</given-names></name><name><surname>Nourshargh</surname><given-names>S</given-names></name><name><surname>Alon</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Leukocytes breach endothelial barriers by insertion of nuclear lobes and disassembly of endothelial actin filaments</article-title><source>Cell Reports</source><volume>18</volume><fpage>685</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.076</pub-id><pub-id pub-id-type="pmid">28099847</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Mächler</surname><given-names>M</given-names></name><name><surname>Bolker</surname><given-names>B</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fitting linear mixed-effects models using lme4</article-title><source>Journal of Statistical Software</source><volume>67</volume><fpage>1</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.18637/jss.v067.i01</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bo</surname><given-names>L</given-names></name><name><surname>Waugh</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Determination of bilayer membrane bending stiffness by tether formation from giant, thin-walled vesicles</article-title><source>Biophysical Journal</source><volume>55</volume><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(89)82844-9</pub-id><pub-id pub-id-type="pmid">2930831</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>L</given-names></name><name><surname>Doye</surname><given-names>A</given-names></name><name><surname>Rolando</surname><given-names>M</given-names></name><name><surname>Flatau</surname><given-names>G</given-names></name><name><surname>Munro</surname><given-names>P</given-names></name><name><surname>Gounon</surname><given-names>P</given-names></name><name><surname>Clément</surname><given-names>R</given-names></name><name><surname>Pulcini</surname><given-names>C</given-names></name><name><surname>Popoff</surname><given-names>MR</given-names></name><name><surname>Mettouchi</surname><given-names>A</given-names></name><name><surname>Landraud</surname><given-names>L</given-names></name><name><surname>Dussurget</surname><given-names>O</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Induction of transient macroapertures in endothelial cells through RhoA inhibition by <italic>Staphylococcus aureus</italic> factors</article-title><source>The Journal of Cell Biology</source><volume>173</volume><fpage>809</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1083/jcb.200509009</pub-id><pub-id pub-id-type="pmid">16754962</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braakman</surname><given-names>ST</given-names></name><name><surname>Read</surname><given-names>AT</given-names></name><name><surname>Chan</surname><given-names>DWH</given-names></name><name><surname>Ethier</surname><given-names>CR</given-names></name><name><surname>Overby</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Colocalization of outflow segmentation and pores along the inner wall of Schlemm’s canal</article-title><source>Experimental Eye Research</source><volume>130</volume><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2014.11.008</pub-id><pub-id pub-id-type="pmid">25450060</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carton</surname><given-names>I</given-names></name><name><surname>Trouet</surname><given-names>D</given-names></name><name><surname>Hermans</surname><given-names>D</given-names></name><name><surname>Barth</surname><given-names>H</given-names></name><name><surname>Aktories</surname><given-names>K</given-names></name><name><surname>Droogmans</surname><given-names>G</given-names></name><name><surname>Jorgensen</surname><given-names>NK</given-names></name><name><surname>Hoffmann</surname><given-names>EK</given-names></name><name><surname>Nilius</surname><given-names>B</given-names></name><name><surname>Eggermont</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>RhoA exerts a permissive effect on volume-regulated anion channels in vascular endothelial cells</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>283</volume><fpage>C115</fpage><lpage>C125</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00038.2001</pub-id><pub-id pub-id-type="pmid">12055079</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chardin</surname><given-names>P</given-names></name><name><surname>Boquet</surname><given-names>P</given-names></name><name><surname>Madaule</surname><given-names>P</given-names></name><name><surname>Popoff</surname><given-names>MR</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name><name><surname>Gill</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells</article-title><source>The EMBO Journal</source><volume>8</volume><fpage>1087</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1989.tb03477.x</pub-id><pub-id pub-id-type="pmid">2501082</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courjon</surname><given-names>J</given-names></name><name><surname>Munro</surname><given-names>P</given-names></name><name><surname>Benito</surname><given-names>Y</given-names></name><name><surname>Visvikis</surname><given-names>O</given-names></name><name><surname>Bouchiat</surname><given-names>C</given-names></name><name><surname>Boyer</surname><given-names>L</given-names></name><name><surname>Doye</surname><given-names>A</given-names></name><name><surname>Lepidi</surname><given-names>H</given-names></name><name><surname>Ghigo</surname><given-names>E</given-names></name><name><surname>Lavigne</surname><given-names>J-P</given-names></name><name><surname>Vandenesch</surname><given-names>F</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>EDIN-B promotes the translocation of <italic>Staphylococcus aureus</italic> to the bloodstream in the course of pneumonia</article-title><source>Toxins</source><volume>7</volume><fpage>4131</fpage><lpage>4142</lpage><pub-id pub-id-type="doi">10.3390/toxins7104131</pub-id><pub-id pub-id-type="pmid">26501320</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuvelier</surname><given-names>D</given-names></name><name><surname>Derényi</surname><given-names>I</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Nassoy</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Coalescence of membrane tethers: experiments, theory, and applications</article-title><source>Biophysical Journal</source><volume>88</volume><fpage>2714</fpage><lpage>2726</lpage><pub-id pub-id-type="doi">10.1529/biophysj.104.056473</pub-id><pub-id pub-id-type="pmid">15695629</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daumke</surname><given-names>O</given-names></name><name><surname>Lundmark</surname><given-names>R</given-names></name><name><surname>Vallis</surname><given-names>Y</given-names></name><name><surname>Martens</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>PJG</given-names></name><name><surname>McMahon</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Architectural and mechanistic insights into an EHD ATPase involved in membrane remodelling</article-title><source>Nature</source><volume>449</volume><fpage>923</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1038/nature06173</pub-id><pub-id pub-id-type="pmid">17914359</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Pozo</surname><given-names>MA</given-names></name><name><surname>Lolo</surname><given-names>FN</given-names></name><name><surname>Echarri</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Caveolae: Mechanosensing and mechanotransduction devices linking membrane trafficking to mechanoadaptation</article-title><source>Current Opinion in Cell Biology</source><volume>68</volume><fpage>113</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2020.10.008</pub-id><pub-id pub-id-type="pmid">33188985</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derényi</surname><given-names>I</given-names></name><name><surname>Jülicher</surname><given-names>F</given-names></name><name><surname>Prost</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Formation and interaction of membrane tubes</article-title><source>Physical Review Letters</source><volume>88</volume><elocation-id>238101</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevLett.88.238101</pub-id><pub-id pub-id-type="pmid">12059401</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewulf</surname><given-names>M</given-names></name><name><surname>Köster</surname><given-names>DV</given-names></name><name><surname>Sinha</surname><given-names>B</given-names></name><name><surname>Viaris de Lesegno</surname><given-names>C</given-names></name><name><surname>Chambon</surname><given-names>V</given-names></name><name><surname>Bigot</surname><given-names>A</given-names></name><name><surname>Bensalah</surname><given-names>M</given-names></name><name><surname>Negroni</surname><given-names>E</given-names></name><name><surname>Tardif</surname><given-names>N</given-names></name><name><surname>Podkalicka</surname><given-names>J</given-names></name><name><surname>Johannes</surname><given-names>L</given-names></name><name><surname>Nassoy</surname><given-names>P</given-names></name><name><surname>Butler-Browne</surname><given-names>G</given-names></name><name><surname>Lamaze</surname><given-names>C</given-names></name><name><surname>Blouin</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dystrophy-associated caveolin-3 mutations reveal that caveolae couple IL6/STAT3 signaling with mechanosensing in human muscle cells</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1974</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09405-5</pub-id><pub-id pub-id-type="pmid">31036801</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doye</surname><given-names>A</given-names></name><name><surname>Mettouchi</surname><given-names>A</given-names></name><name><surname>Bossis</surname><given-names>G</given-names></name><name><surname>Clément</surname><given-names>R</given-names></name><name><surname>Buisson-Touati</surname><given-names>C</given-names></name><name><surname>Flatau</surname><given-names>G</given-names></name><name><surname>Gagnoux</surname><given-names>L</given-names></name><name><surname>Piechaczyk</surname><given-names>M</given-names></name><name><surname>Boquet</surname><given-names>P</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion</article-title><source>Cell</source><volume>111</volume><fpage>553</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(02)01132-7</pub-id><pub-id pub-id-type="pmid">12437928</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>E</given-names></name><name><surname>Rawicz</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Entropy-driven tension and bending elasticity in condensed-fluid membranes</article-title><source>Physical Review Letters</source><volume>64</volume><fpage>2094</fpage><lpage>2097</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.64.2094</pub-id><pub-id pub-id-type="pmid">10041575</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>PW</given-names></name><name><surname>Hélie</surname><given-names>J</given-names></name><name><surname>Duncan</surname><given-names>A</given-names></name><name><surname>Chavent</surname><given-names>M</given-names></name><name><surname>Koldsø</surname><given-names>H</given-names></name><name><surname>Sansom</surname><given-names>MSP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Membrane stiffness is modified by integral membrane proteins</article-title><source>Soft Matter</source><volume>12</volume><fpage>7792</fpage><lpage>7803</lpage><pub-id pub-id-type="doi">10.1039/c6sm01186a</pub-id><pub-id pub-id-type="pmid">27722554</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillet</surname><given-names>Y</given-names></name><name><surname>Tristan</surname><given-names>A</given-names></name><name><surname>Rasigade</surname><given-names>J-P</given-names></name><name><surname>Saadatian-Elahi</surname><given-names>M</given-names></name><name><surname>Bouchiat</surname><given-names>C</given-names></name><name><surname>Bes</surname><given-names>M</given-names></name><name><surname>Dumitrescu</surname><given-names>O</given-names></name><name><surname>Leloire</surname><given-names>M</given-names></name><name><surname>Dupieux</surname><given-names>C</given-names></name><name><surname>Laurent</surname><given-names>F</given-names></name><name><surname>Lina</surname><given-names>G</given-names></name><name><surname>Etienne</surname><given-names>J</given-names></name><name><surname>Vanhems</surname><given-names>P</given-names></name><name><surname>Argaud</surname><given-names>L</given-names></name><name><surname>Vandenesch</surname><given-names>F</given-names></name><collab>PVL pneumonia study group</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Prognostic factors of severe community-acquired staphylococcal pneumonia in France</article-title><source>The European Respiratory Journal</source><volume>58</volume><elocation-id>2004445</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.04445-2020</pub-id><pub-id pub-id-type="pmid">33833037</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>P</given-names></name><name><surname>Prost</surname><given-names>J</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Passive or active fluctuations in membranes containing proteins</article-title><source>Physical Review Letters</source><volume>94</volume><elocation-id>088102</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevLett.94.088102</pub-id><pub-id pub-id-type="pmid">15783939</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Rodriguez</surname><given-names>D</given-names></name><name><surname>Maddugoda</surname><given-names>MP</given-names></name><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Janel</surname><given-names>S</given-names></name><name><surname>Lafont</surname><given-names>F</given-names></name><name><surname>Cuvelier</surname><given-names>D</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name><name><surname>Brochard-Wyart</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cellular dewetting: opening of macroapertures in endothelial cells</article-title><source>Physical Review Letters</source><volume>108</volume><elocation-id>218105</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevLett.108.218105</pub-id><pub-id pub-id-type="pmid">23003307</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Rodriguez</surname><given-names>D</given-names></name><name><surname>Morel</surname><given-names>C</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dewetting: From physics to the biology of intoxicated cells</article-title><source>Advances in Experimental Medicine and Biology</source><volume>1267</volume><fpage>101</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-46886-6_6</pub-id><pub-id pub-id-type="pmid">32894479</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Guevorkian</surname><given-names>K</given-names></name><name><surname>Brochard-Wyart</surname><given-names>F</given-names></name><name><surname>Gonzalez-Rodriguez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><chapter-title>Flow Dynamics of 3d Multicellular systems into Capillaries</chapter-title><person-group person-group-type="editor"><name><surname>Pajic-Lijakovic</surname><given-names>I</given-names></name><name><surname>Barriga</surname><given-names>EH</given-names></name></person-group><source>Viscoelasticity and Collective Cell Migration</source><publisher-name>Academic Press</publisher-name><fpage>193</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-820310-1.00008-2</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Plasmalemma vesicle-associated protein: A crucial component of vascular homeostasis</article-title><source>Experimental and Therapeutic Medicine</source><volume>12</volume><fpage>1639</fpage><lpage>1644</lpage><pub-id pub-id-type="doi">10.3892/etm.2016.3557</pub-id><pub-id pub-id-type="pmid">27602081</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helfrich</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1973">1973</year><article-title>Elastic properties of lipid bilayers: theory and possible experiments</article-title><source>Zeitschrift Fur Naturforschung. Teil C</source><volume>28</volume><fpage>693</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1515/znc-1973-11-1209</pub-id><pub-id pub-id-type="pmid">4273690</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heuser</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The production of “cell cortices” for light and electron microscopy</article-title><source>Traffic</source><volume>1</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0854.2000.010704.x</pub-id><pub-id pub-id-type="pmid">11208142</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>MM</given-names></name><name><surname>Bastiani</surname><given-names>M</given-names></name><name><surname>Luetterforst</surname><given-names>R</given-names></name><name><surname>Kirkham</surname><given-names>M</given-names></name><name><surname>Kirkham</surname><given-names>A</given-names></name><name><surname>Nixon</surname><given-names>SJ</given-names></name><name><surname>Walser</surname><given-names>P</given-names></name><name><surname>Abankwa</surname><given-names>D</given-names></name><name><surname>Oorschot</surname><given-names>VMJ</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Hancock</surname><given-names>JF</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function</article-title><source>Cell</source><volume>132</volume><fpage>113</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.11.042</pub-id><pub-id pub-id-type="pmid">18191225</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansa</surname><given-names>P</given-names></name><name><surname>Grummt</surname><given-names>I</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mechanism of transcription termination: PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse</article-title><source>Molecular &amp; General Genetics</source><volume>262</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1007/s004380051112</pub-id><pub-id pub-id-type="pmid">10589839</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansa</surname><given-names>P</given-names></name><name><surname>Burek</surname><given-names>C</given-names></name><name><surname>Sander</surname><given-names>EE</given-names></name><name><surname>Grummt</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The transcript release factor PTRF augments ribosomal gene transcription by facilitating reinitiation of RNA polymerase I</article-title><source>Nucleic Acids Research</source><volume>29</volume><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1093/nar/29.2.423</pub-id><pub-id pub-id-type="pmid">11139612</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komarova</surname><given-names>YA</given-names></name><name><surname>Kruse</surname><given-names>K</given-names></name><name><surname>Mehta</surname><given-names>D</given-names></name><name><surname>Malik</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability</article-title><source>Circulation Research</source><volume>120</volume><fpage>179</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.306534</pub-id><pub-id pub-id-type="pmid">28057793</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuznetsova</surname><given-names>A</given-names></name><name><surname>Brockhoff</surname><given-names>PB</given-names></name><name><surname>Christensen</surname><given-names>RHB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>lmertest package: tests in linear mixed effects models</article-title><source>Journal of Statistical Software</source><volume>82</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.18637/jss.v082.i13</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamaze</surname><given-names>C</given-names></name><name><surname>Tardif</surname><given-names>N</given-names></name><name><surname>Dewulf</surname><given-names>M</given-names></name><name><surname>Vassilopoulos</surname><given-names>S</given-names></name><name><surname>Blouin</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The caveolae dress code: structure and signaling</article-title><source>Current Opinion in Cell Biology</source><volume>47</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2017.02.014</pub-id><pub-id pub-id-type="pmid">28641181</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemerle</surname><given-names>E</given-names></name><name><surname>Lainé</surname><given-names>J</given-names></name><name><surname>Benoist</surname><given-names>M</given-names></name><name><surname>Moulay</surname><given-names>G</given-names></name><name><surname>Bigot</surname><given-names>A</given-names></name><name><surname>Labasse</surname><given-names>C</given-names></name><name><surname>Madelaine</surname><given-names>A</given-names></name><name><surname>Canette</surname><given-names>A</given-names></name><name><surname>Aubin</surname><given-names>P</given-names></name><name><surname>Vallat</surname><given-names>J-M</given-names></name><name><surname>Romero</surname><given-names>NB</given-names></name><name><surname>Bitoun</surname><given-names>M</given-names></name><name><surname>Mouly</surname><given-names>V</given-names></name><name><surname>Marty</surname><given-names>I</given-names></name><name><surname>Cadot</surname><given-names>B</given-names></name><name><surname>Picas</surname><given-names>L</given-names></name><name><surname>Vassilopoulos</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Caveolae and Bin1 form ring-shaped platforms for T-tubule initiation</article-title><source>eLife</source><volume>12</volume><elocation-id>e84139</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.84139</pub-id><pub-id pub-id-type="pmid">37083699</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemichez</surname><given-names>E</given-names></name><name><surname>Gonzalez-Rodriguez</surname><given-names>D</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Brochard-Wyart</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transcellular tunnel dynamics: Control of cellular dewetting by actomyosin contractility and I-BAR proteins</article-title><source>Biology of the Cell</source><volume>105</volume><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1111/boc.201200063</pub-id><pub-id pub-id-type="pmid">23189935</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mechanical properties of tunneling nanotube and its mechanical stability in human embryonic kidney cells</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>10</volume><elocation-id>955676</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2022.955676</pub-id><pub-id pub-id-type="pmid">36238686</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lingwood</surname><given-names>D</given-names></name><name><surname>Ries</surname><given-names>J</given-names></name><name><surname>Schwille</surname><given-names>P</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Plasma membranes are poised for activation of raft phase coalescence at physiological temperature</article-title><source>PNAS</source><volume>105</volume><fpage>10005</fpage><lpage>10010</lpage><pub-id pub-id-type="doi">10.1073/pnas.0804374105</pub-id><pub-id pub-id-type="pmid">18621689</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Pilch</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges</article-title><source>eLife</source><volume>5</volume><elocation-id>e17508</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17508</pub-id><pub-id pub-id-type="pmid">27528195</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Mendoza-Topaz</surname><given-names>C</given-names></name><name><surname>Deerinck</surname><given-names>T</given-names></name><name><surname>Mackey</surname><given-names>M</given-names></name><name><surname>Sandin</surname><given-names>S</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name><name><surname>Nichols</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular composition and ultrastructure of the caveolar coat complex</article-title><source>PLOS Biology</source><volume>11</volume><elocation-id>e1001640</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001640</pub-id><pub-id pub-id-type="pmid">24013648</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Nichols</surname><given-names>BJ</given-names></name><name><surname>Sandin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Architecture of the caveolar coat complex</article-title><source>Journal of Cell Science</source><volume>129</volume><fpage>3077</fpage><lpage>3083</lpage><pub-id pub-id-type="doi">10.1242/jcs.191262</pub-id><pub-id pub-id-type="pmid">27369768</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>FS</given-names></name><name><surname>Rodriguez</surname><given-names>NE</given-names></name><name><surname>Adesse</surname><given-names>D</given-names></name><name><surname>Garzoni</surname><given-names>LR</given-names></name><name><surname>Esper</surname><given-names>L</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name><name><surname>Burk</surname><given-names>RD</given-names></name><name><surname>Albanese</surname><given-names>C</given-names></name><name><surname>Van Doorslaer</surname><given-names>K</given-names></name><name><surname>Weiss</surname><given-names>LM</given-names></name><name><surname>Nagajyothi</surname><given-names>F</given-names></name><name><surname>Nosanchuk</surname><given-names>JD</given-names></name><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Tanowitz</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Recent developments in the interactions between caveolin and pathogens</article-title><source>Advances in Experimental Medicine and Biology</source><volume>729</volume><fpage>65</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/978-1-4614-1222-9_5</pub-id><pub-id pub-id-type="pmid">22411314</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maddugoda</surname><given-names>MP</given-names></name><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Gonzalez-Rodriguez</surname><given-names>D</given-names></name><name><surname>Saarikangas</surname><given-names>J</given-names></name><name><surname>Torrino</surname><given-names>S</given-names></name><name><surname>Janel</surname><given-names>S</given-names></name><name><surname>Munro</surname><given-names>P</given-names></name><name><surname>Doye</surname><given-names>A</given-names></name><name><surname>Prodon</surname><given-names>F</given-names></name><name><surname>Aurrand-Lions</surname><given-names>M</given-names></name><name><surname>Goossens</surname><given-names>PL</given-names></name><name><surname>Lafont</surname><given-names>F</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Lappalainen</surname><given-names>P</given-names></name><name><surname>Brochard</surname><given-names>F</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>cAMP signaling by anthrax edema toxin induces transendothelial cell tunnels, which are resealed by MIM via Arp2/3-driven actin polymerization</article-title><source>Cell Host &amp; Microbe</source><volume>10</volume><fpage>464</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2011.09.014</pub-id><pub-id pub-id-type="pmid">22100162</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manneville</surname><given-names>JB</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Lévy</surname><given-names>D</given-names></name><name><surname>Prost</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Activity of transmembrane proteins induces magnification of shape fluctuations of lipid membranes</article-title><source>Physical Review Letters</source><volume>82</volume><fpage>4356</fpage><lpage>4359</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.82.4356</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>FA</given-names></name><name><surname>de Almeida</surname><given-names>CJ</given-names></name><name><surname>Dew</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Bonuccelli</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>TM</given-names></name><name><surname>Cohen</surname><given-names>AW</given-names></name><name><surname>Pestell</surname><given-names>RG</given-names></name><name><surname>Frank</surname><given-names>PG</given-names></name><name><surname>Tanowitz</surname><given-names>HB</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during <italic>Salmonella enterica</italic> serovar Typhimurium infection</article-title><source>Infection and Immunity</source><volume>74</volume><fpage>6665</fpage><lpage>6674</lpage><pub-id pub-id-type="doi">10.1128/IAI.00949-06</pub-id><pub-id pub-id-type="pmid">16982844</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyawaki-Shimizu</surname><given-names>K</given-names></name><name><surname>Predescu</surname><given-names>D</given-names></name><name><surname>Shimizu</surname><given-names>J</given-names></name><name><surname>Broman</surname><given-names>M</given-names></name><name><surname>Predescu</surname><given-names>S</given-names></name><name><surname>Malik</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>290</volume><fpage>L405</fpage><lpage>L413</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00292.2005</pub-id><pub-id pub-id-type="pmid">16183667</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>P</given-names></name><name><surname>Benchetrit</surname><given-names>M</given-names></name><name><surname>Nahori</surname><given-names>M-A</given-names></name><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Clément</surname><given-names>R</given-names></name><name><surname>Michiels</surname><given-names>J-F</given-names></name><name><surname>Landraud</surname><given-names>L</given-names></name><name><surname>Dussurget</surname><given-names>O</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The <italic>Staphylococcus aureus</italic> epidermal cell differentiation inhibitor toxin promotes formation of infection foci in a mouse model of bacteremia</article-title><source>Infection and Immunity</source><volume>78</volume><fpage>3404</fpage><lpage>3411</lpage><pub-id pub-id-type="doi">10.1128/IAI.00319-10</pub-id><pub-id pub-id-type="pmid">20479081</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>WP</given-names></name><name><surname>Webster</surname><given-names>KD</given-names></name><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Schmid</surname><given-names>EM</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Fletcher</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Force-induced transcellular tunnel formation in endothelial cells</article-title><source>Molecular Biology of the Cell</source><volume>28</volume><fpage>2650</fpage><lpage>2660</lpage><pub-id pub-id-type="doi">10.1091/mbc.E17-01-0080</pub-id><pub-id pub-id-type="pmid">28794268</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Suetsugu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Super-resolution analysis of PACSIN2 and EHD2 at caveolae</article-title><source>PLOS ONE</source><volume>17</volume><elocation-id>e0271003</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0271003</pub-id><pub-id pub-id-type="pmid">35834519</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Hanzal-Bayer</surname><given-names>M</given-names></name><name><surname>Hancock</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Biogenesis of caveolae: a structural model for caveolin-induced domain formation</article-title><source>Journal of Cell Science</source><volume>119</volume><fpage>787</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1242/jcs.02853</pub-id><pub-id pub-id-type="pmid">16495479</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Del Pozo</surname><given-names>MA</given-names></name><name><surname>Vassilopoulos</surname><given-names>S</given-names></name><name><surname>Nabi</surname><given-names>IR</given-names></name><name><surname>Le Lay</surname><given-names>S</given-names></name><name><surname>Lundmark</surname><given-names>R</given-names></name><name><surname>Kenworthy</surname><given-names>AK</given-names></name><name><surname>Camus</surname><given-names>A</given-names></name><name><surname>Blouin</surname><given-names>CM</given-names></name><name><surname>Sessa</surname><given-names>WC</given-names></name><name><surname>Lamaze</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Caveolae: the faqs</article-title><source>Traffic</source><volume>21</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1111/tra.12689</pub-id><pub-id pub-id-type="pmid">31448516</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Kozlov</surname><given-names>MM</given-names></name><name><surname>Ariotti</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Caveolae and lipid sorting: Shaping the cellular response to stress</article-title><source>The Journal of Cell Biology</source><volume>219</volume><elocation-id>e201905071</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.201905071</pub-id><pub-id pub-id-type="pmid">32328645</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>HF</given-names></name><name><surname>Self</surname><given-names>AJ</given-names></name><name><surname>Garrett</surname><given-names>MD</given-names></name><name><surname>Just</surname><given-names>I</given-names></name><name><surname>Aktories</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Microinjection of recombinant p21rho induces rapid changes in cell morphology</article-title><source>The Journal of Cell Biology</source><volume>111</volume><fpage>1001</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1083/jcb.111.3.1001</pub-id><pub-id pub-id-type="pmid">2118140</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perret</surname><given-names>M</given-names></name><name><surname>Badiou</surname><given-names>C</given-names></name><name><surname>Lina</surname><given-names>G</given-names></name><name><surname>Burbaud</surname><given-names>S</given-names></name><name><surname>Benito</surname><given-names>Y</given-names></name><name><surname>Bes</surname><given-names>M</given-names></name><name><surname>Cottin</surname><given-names>V</given-names></name><name><surname>Couzon</surname><given-names>F</given-names></name><name><surname>Juruj</surname><given-names>C</given-names></name><name><surname>Dauwalder</surname><given-names>O</given-names></name><name><surname>Goutagny</surname><given-names>N</given-names></name><name><surname>Diep</surname><given-names>BA</given-names></name><name><surname>Vandenesch</surname><given-names>F</given-names></name><name><surname>Henry</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cross-talk between <italic>Staphylococcus aureus</italic> leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner</article-title><source>Cellular Microbiology</source><volume>14</volume><fpage>1019</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2012.01772.x</pub-id><pub-id pub-id-type="pmid">22329718</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porta</surname><given-names>JC</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Gulsevin</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>JM</given-names></name><name><surname>Peskova</surname><given-names>Y</given-names></name><name><surname>Connolly</surname><given-names>S</given-names></name><name><surname>Mchaourab</surname><given-names>HS</given-names></name><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Karakas</surname><given-names>E</given-names></name><name><surname>Kenworthy</surname><given-names>AK</given-names></name><name><surname>Ohi</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Molecular architecture of the human caveolin-1 complex</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabn7232</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abn7232</pub-id><pub-id pub-id-type="pmid">35544577</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raucher</surname><given-names>D</given-names></name><name><surname>Sheetz</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cell spreading and lamellipodial extension rate is regulated by membrane tension</article-title><source>The Journal of Cell Biology</source><volume>148</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1083/jcb.148.1.127</pub-id><pub-id pub-id-type="pmid">10629223</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawicz</surname><given-names>W</given-names></name><name><surname>Smith</surname><given-names>BA</given-names></name><name><surname>McIntosh</surname><given-names>TJ</given-names></name><name><surname>Simon</surname><given-names>SA</given-names></name><name><surname>Evans</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Elasticity, strength, and water permeability of bilayers that contain raft microdomain-forming lipids</article-title><source>Biophysical Journal</source><volume>94</volume><fpage>4725</fpage><lpage>4736</lpage><pub-id pub-id-type="doi">10.1529/biophysj.107.121731</pub-id><pub-id pub-id-type="pmid">18339739</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razani</surname><given-names>B</given-names></name><name><surname>Engelman</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>XB</given-names></name><name><surname>Schubert</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><name><surname>Marks</surname><given-names>CB</given-names></name><name><surname>Macaluso</surname><given-names>F</given-names></name><name><surname>Russell</surname><given-names>RG</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Pestell</surname><given-names>RG</given-names></name><name><surname>Di Vizio</surname><given-names>D</given-names></name><name><surname>Hou</surname><given-names>H</given-names><suffix>Jr</suffix></name><name><surname>Kneitz</surname><given-names>B</given-names></name><name><surname>Lagaud</surname><given-names>G</given-names></name><name><surname>Christ</surname><given-names>GJ</given-names></name><name><surname>Edelmann</surname><given-names>W</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>38121</fpage><lpage>38138</lpage><pub-id pub-id-type="doi">10.1074/jbc.M105408200</pub-id><pub-id pub-id-type="pmid">11457855</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roitenberg</surname><given-names>N</given-names></name><name><surname>Bejerano-Sagie</surname><given-names>M</given-names></name><name><surname>Boocholez</surname><given-names>H</given-names></name><name><surname>Moll</surname><given-names>L</given-names></name><name><surname>Marques</surname><given-names>FC</given-names></name><name><surname>Golodetzki</surname><given-names>L</given-names></name><name><surname>Nevo</surname><given-names>Y</given-names></name><name><surname>Elami</surname><given-names>T</given-names></name><name><surname>Cohen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modulation of caveolae by insulin/IGF-1 signaling regulates aging of <italic>Caenorhabditis elegans</italic></article-title><source>EMBO Reports</source><volume>19</volume><elocation-id>e45673</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201745673</pub-id><pub-id pub-id-type="pmid">29945933</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolando</surname><given-names>M</given-names></name><name><surname>Munro</surname><given-names>P</given-names></name><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Auberger</surname><given-names>P</given-names></name><name><surname>Flatau</surname><given-names>G</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Injection of <italic>Staphylococcus aureus</italic> EDIN by the Bacillus anthracis protective antigen machinery induces vascular permeability</article-title><source>Infection and Immunity</source><volume>77</volume><fpage>3596</fpage><lpage>3601</lpage><pub-id pub-id-type="doi">10.1128/IAI.00186-09</pub-id><pub-id pub-id-type="pmid">19546197</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sens</surname><given-names>P</given-names></name><name><surname>Plastino</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Membrane tension and cytoskeleton organization in cell motility</article-title><source>Journal of Physics</source><volume>27</volume><elocation-id>273103</elocation-id><pub-id pub-id-type="doi">10.1088/0953-8984/27/27/273103</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>S-H</given-names></name><name><surname>Ng</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>N-D</given-names></name><name><surname>Koo</surname><given-names>G-B</given-names></name><name><surname>McMahon</surname><given-names>K-A</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Hill</surname><given-names>MM</given-names></name><name><surname>Del Pozo</surname><given-names>MA</given-names></name><name><surname>Kim</surname><given-names>Y-S</given-names></name><name><surname>Shen</surname><given-names>H-M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy</article-title><source>Autophagy</source><volume>11</volume><fpage>769</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1034411</pub-id><pub-id pub-id-type="pmid">25945613</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>MR</given-names></name><name><surname>Komarova</surname><given-names>YA</given-names></name><name><surname>Vogel</surname><given-names>SM</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Bonini</surname><given-names>MG</given-names></name><name><surname>Rajasingh</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y-Y</given-names></name><name><surname>Brovkovych</surname><given-names>V</given-names></name><name><surname>Malik</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability</article-title><source>The Journal of Cell Biology</source><volume>193</volume><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1083/jcb.201012129</pub-id><pub-id pub-id-type="pmid">21624953</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>B</given-names></name><name><surname>Köster</surname><given-names>D</given-names></name><name><surname>Ruez</surname><given-names>R</given-names></name><name><surname>Gonnord</surname><given-names>P</given-names></name><name><surname>Bastiani</surname><given-names>M</given-names></name><name><surname>Abankwa</surname><given-names>D</given-names></name><name><surname>Stan</surname><given-names>RV</given-names></name><name><surname>Butler-Browne</surname><given-names>G</given-names></name><name><surname>Vedie</surname><given-names>B</given-names></name><name><surname>Johannes</surname><given-names>L</given-names></name><name><surname>Morone</surname><given-names>N</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Raposo</surname><given-names>G</given-names></name><name><surname>Sens</surname><given-names>P</given-names></name><name><surname>Lamaze</surname><given-names>C</given-names></name><name><surname>Nassoy</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cells respond to mechanical stress by rapid disassembly of caveolae</article-title><source>Cell</source><volume>144</volume><fpage>402</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.12.031</pub-id><pub-id pub-id-type="pmid">21295700</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorre</surname><given-names>B</given-names></name><name><surname>Callan-Jones</surname><given-names>A</given-names></name><name><surname>Manzi</surname><given-names>J</given-names></name><name><surname>Goud</surname><given-names>B</given-names></name><name><surname>Prost</surname><given-names>J</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Roux</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nature of curvature coupling of amphiphysin with membranes depends on its bound density</article-title><source>PNAS</source><volume>109</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1073/pnas.1103594108</pub-id><pub-id pub-id-type="pmid">22184226</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaan</surname><given-names>AN</given-names></name><name><surname>Neehus</surname><given-names>A-L</given-names></name><name><surname>Laplantine</surname><given-names>E</given-names></name><name><surname>Staels</surname><given-names>F</given-names></name><name><surname>Ogishi</surname><given-names>M</given-names></name><name><surname>Seeleuthner</surname><given-names>Y</given-names></name><name><surname>Rapaport</surname><given-names>F</given-names></name><name><surname>Lacey</surname><given-names>KA</given-names></name><name><surname>Van Nieuwenhove</surname><given-names>E</given-names></name><name><surname>Chrabieh</surname><given-names>M</given-names></name><name><surname>Hum</surname><given-names>D</given-names></name><name><surname>Migaud</surname><given-names>M</given-names></name><name><surname>Izmiryan</surname><given-names>A</given-names></name><name><surname>Lorenzo</surname><given-names>L</given-names></name><name><surname>Kochetkov</surname><given-names>T</given-names></name><name><surname>Heesterbeek</surname><given-names>DAC</given-names></name><name><surname>Bardoel</surname><given-names>BW</given-names></name><name><surname>DuMont</surname><given-names>AL</given-names></name><name><surname>Dobbs</surname><given-names>K</given-names></name><name><surname>Chardonnet</surname><given-names>S</given-names></name><name><surname>Heissel</surname><given-names>S</given-names></name><name><surname>Baslan</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Bogunovic</surname><given-names>D</given-names></name><name><surname>Wunderink</surname><given-names>HF</given-names></name><name><surname>Haas</surname><given-names>P-JA</given-names></name><name><surname>Molina</surname><given-names>H</given-names></name><name><surname>Van Buggenhout</surname><given-names>G</given-names></name><name><surname>Lyonnet</surname><given-names>S</given-names></name><name><surname>Notarangelo</surname><given-names>LD</given-names></name><name><surname>Seppänen</surname><given-names>MRJ</given-names></name><name><surname>Weil</surname><given-names>R</given-names></name><name><surname>Seminario</surname><given-names>G</given-names></name><name><surname>Gomez-Tello</surname><given-names>H</given-names></name><name><surname>Wouters</surname><given-names>C</given-names></name><name><surname>Mesdaghi</surname><given-names>M</given-names></name><name><surname>Shahrooei</surname><given-names>M</given-names></name><name><surname>Bossuyt</surname><given-names>X</given-names></name><name><surname>Sag</surname><given-names>E</given-names></name><name><surname>Topaloglu</surname><given-names>R</given-names></name><name><surname>Ozen</surname><given-names>S</given-names></name><name><surname>Leavis</surname><given-names>HL</given-names></name><name><surname>van Eijk</surname><given-names>MMJ</given-names></name><name><surname>Bezrodnik</surname><given-names>L</given-names></name><name><surname>Blancas Galicia</surname><given-names>L</given-names></name><name><surname>Hovnanian</surname><given-names>A</given-names></name><name><surname>Nassif</surname><given-names>A</given-names></name><name><surname>Bader-Meunier</surname><given-names>B</given-names></name><name><surname>Neven</surname><given-names>B</given-names></name><name><surname>Meyts</surname><given-names>I</given-names></name><name><surname>Schrijvers</surname><given-names>R</given-names></name><name><surname>Puel</surname><given-names>A</given-names></name><name><surname>Bustamante</surname><given-names>J</given-names></name><name><surname>Aksentijevich</surname><given-names>I</given-names></name><name><surname>Kastner</surname><given-names>DL</given-names></name><name><surname>Torres</surname><given-names>VJ</given-names></name><name><surname>Humblet-Baron</surname><given-names>S</given-names></name><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>Boisson</surname><given-names>B</given-names></name><name><surname>Casanova</surname><given-names>J-L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin</article-title><source>Science</source><volume>376</volume><elocation-id>eabm6380</elocation-id><pub-id pub-id-type="doi">10.1126/science.abm6380</pub-id><pub-id pub-id-type="pmid">35587511</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Gonzalez-Rodriguez</surname><given-names>D</given-names></name><name><surname>Senju</surname><given-names>Y</given-names></name><name><surname>Doye</surname><given-names>A</given-names></name><name><surname>Efimova</surname><given-names>N</given-names></name><name><surname>Janel</surname><given-names>S</given-names></name><name><surname>Lipuma</surname><given-names>J</given-names></name><name><surname>Tsai</surname><given-names>MC</given-names></name><name><surname>Hamaoui</surname><given-names>D</given-names></name><name><surname>Maddugoda</surname><given-names>MP</given-names></name><name><surname>Cochet-Escartin</surname><given-names>O</given-names></name><name><surname>Prévost</surname><given-names>C</given-names></name><name><surname>Lafont</surname><given-names>F</given-names></name><name><surname>Svitkina</surname><given-names>T</given-names></name><name><surname>Lappalainen</surname><given-names>P</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ezrin enhances line tension along transcellular tunnel edges via NMIIa driven actomyosin cable formation</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15839</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15839</pub-id><pub-id pub-id-type="pmid">28643776</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinkühler</surname><given-names>J</given-names></name><name><surname>Sezgin</surname><given-names>E</given-names></name><name><surname>Urbančič</surname><given-names>I</given-names></name><name><surname>Eggeling</surname><given-names>C</given-names></name><name><surname>Dimova</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mechanical properties of plasma membrane vesicles correlate with lipid order, viscosity and cell density</article-title><source>Communications Biology</source><volume>2</volume><elocation-id>337</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-019-0583-3</pub-id><pub-id pub-id-type="pmid">31531398</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugai</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Okumura</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Ohgai</surname><given-names>H</given-names></name><name><surname>Moriishi</surname><given-names>K</given-names></name><name><surname>Syuto</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis</article-title><source>The Journal of Biological Chemistry</source><volume>267</volume><fpage>2600</fpage><lpage>2604</lpage><pub-id pub-id-type="pmid">1733958</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tristan</surname><given-names>A</given-names></name><name><surname>Bes</surname><given-names>M</given-names></name><name><surname>Meugnier</surname><given-names>H</given-names></name><name><surname>Lina</surname><given-names>G</given-names></name><name><surname>Bozdogan</surname><given-names>B</given-names></name><name><surname>Courvalin</surname><given-names>P</given-names></name><name><surname>Reverdy</surname><given-names>M-E</given-names></name><name><surname>Enright</surname><given-names>MC</given-names></name><name><surname>Vandenesch</surname><given-names>F</given-names></name><name><surname>Etienne</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Global distribution of panton-valentine leukocidin--positive methicillin-resistant <italic>Staphylococcus aureus</italic>, 2006</article-title><source>Emerging Infectious Diseases</source><volume>13</volume><fpage>594</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.3201/eid1304.061316</pub-id><pub-id pub-id-type="pmid">17553275</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>M-C</given-names></name><name><surname>Fleuriot</surname><given-names>L</given-names></name><name><surname>Janel</surname><given-names>S</given-names></name><name><surname>Gonzalez-Rodriguez</surname><given-names>D</given-names></name><name><surname>Morel</surname><given-names>C</given-names></name><name><surname>Mettouchi</surname><given-names>A</given-names></name><name><surname>Debayle</surname><given-names>D</given-names></name><name><surname>Dallongeville</surname><given-names>S</given-names></name><name><surname>Olivo-Marin</surname><given-names>J-C</given-names></name><name><surname>Antonny</surname><given-names>B</given-names></name><name><surname>Lafont</surname><given-names>F</given-names></name><name><surname>Lemichez</surname><given-names>E</given-names></name><name><surname>Barelli</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>DHA-containing phospholipids control membrane fusion and transcellular tunnel dynamics</article-title><source>Journal of Cell Science</source><volume>135</volume><elocation-id>jcs259119</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.259119</pub-id><pub-id pub-id-type="pmid">34878112</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Walt</surname><given-names>S</given-names></name><name><surname>Schönberger</surname><given-names>JL</given-names></name><name><surname>Nunez-Iglesias</surname><given-names>J</given-names></name><name><surname>Boulogne</surname><given-names>F</given-names></name><name><surname>Warner</surname><given-names>JD</given-names></name><name><surname>Yager</surname><given-names>N</given-names></name><name><surname>Gouillart</surname><given-names>E</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><collab>scikit-image contributors</collab></person-group><year iso-8601-date="2014">2014</year><article-title>scikit-image: image processing in Python</article-title><source>PeerJ</source><volume>2</volume><elocation-id>e453</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.453</pub-id><pub-id pub-id-type="pmid">25024921</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Controlling cellular volume via mechanical and physical properties of substrate</article-title><source>Biophysical Journal</source><volume>114</volume><fpage>675</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2017.11.3785</pub-id><pub-id pub-id-type="pmid">29414713</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Scarlata</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Super-resolution visualization of caveola deformation in response to osmotic stress</article-title><source>The Journal of Biological Chemistry</source><volume>292</volume><fpage>3779</fpage><lpage>3788</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.768499</pub-id><pub-id pub-id-type="pmid">28096469</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeow</surname><given-names>I</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Chadwick</surname><given-names>J</given-names></name><name><surname>Mendoza-Topaz</surname><given-names>C</given-names></name><name><surname>Hansen</surname><given-names>CG</given-names></name><name><surname>Nichols</surname><given-names>BJ</given-names></name><name><surname>Shvets</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>EHD proteins cooperate to generate caveolar clusters and to maintain caveolae during repeated mechanical stress</article-title><source>Current Biology</source><volume>27</volume><fpage>2951</fpage><lpage>2962</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2017.07.047</pub-id><pub-id pub-id-type="pmid">28943089</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Bergaya</surname><given-names>S</given-names></name><name><surname>Murata</surname><given-names>T</given-names></name><name><surname>Alp</surname><given-names>IF</given-names></name><name><surname>Bauer</surname><given-names>MP</given-names></name><name><surname>Lin</surname><given-names>MI</given-names></name><name><surname>Drab</surname><given-names>M</given-names></name><name><surname>Kurzchalia</surname><given-names>TV</given-names></name><name><surname>Stan</surname><given-names>RV</given-names></name><name><surname>Sessa</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels</article-title><source>The Journal of Clinical Investigation</source><volume>116</volume><fpage>1284</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1172/JCI27100</pub-id><pub-id pub-id-type="pmid">16670769</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zlotek-Zlotkiewicz</surname><given-names>E</given-names></name><name><surname>Monnier</surname><given-names>S</given-names></name><name><surname>Cappello</surname><given-names>G</given-names></name><name><surname>Le Berre</surname><given-names>M</given-names></name><name><surname>Piel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Optical volume and mass measurements show that mammalian cells swell during mitosis</article-title><source>The Journal of Cell Biology</source><volume>211</volume><fpage>765</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1083/jcb.201505056</pub-id><pub-id pub-id-type="pmid">26598614</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92078.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mukherjee</surname><given-names>Shaeri</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study identifies the role of caveolin-1 and cavin1 as regulators of transendothelial macroaperture (TEM). The methodology used is rigorous and <bold>compelling</bold>, and further research can point to more mechanistic understanding of the process.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92078.3.sa1</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The manuscript by Morel et al. aims at identifying some potential mechano-regulators of transendothelial cell macro-aperture (TEM). Guided by the recognized role of caveolar invaginations in buffering the membrane tension of cells, the authors focused on caveolin-1 and associated regulator PTRF. They report a comprehensive <italic>in vitro</italic> work based on siRNA knockdown and optical imaging approach complemented with an <italic>in vivo</italic> work on mice, a biophysical assay allowing to measure the mechanical properties of membranes and a theoretical analysis inspired from soft matter physics.</p><p>The authors should be complimented for this multi-facetted and rigorous work. The accumulation of pieces of evidence collected from each type of approach makes very convincing the conclusion drawn by the authors on the new role of cavolin-1 as an individual protein instead of the main molecular component of caveolae. On a personal note, I was very impressed by the quality of STORM images (Fig. 2) which are very illuminating and useful, in particular for validating some hypotheses of the theoretical analysis.</p><p>While this work pins down the key role of caveolin-1, its mechanism remains to be further investigated. The hypotheses proposed by the authors in the discussions about the link between caveolin and lipids/cholesterol are very plausible though challenging. Even though we may feel slightly frustrated by the absence of data in this direction, the quality and merit of this paper remain.</p><p>The analogy with dewetting processes drawn to derive the theoretical model is very attractive. However, and although part of the model has already been published several times by the same group of authors, the validity of the Helfrich formalism is a key assumption that has to be explained clearly. Here, for the first time, thanks to these STORM analysis, the authors show that HUVECs intoxicated by ExoC3 exhibit a loose and defective cortex with a significantly increase mesh size, which supports this hypothesis.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92078.3.sa2</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Morel</surname><given-names>Camille</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur, Université Paris Cité, CNRS UMR6047, Inserm U1306, Unité des Toxines Bactériennes, Département de Microbiologie</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Lemerle</surname><given-names>Eline</given-names></name><role specific-use="author">Author</role><aff><institution>Sorbonne Université, INSERM UMR974, Institut de Myologie, Centre de Recherche en Myologie</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>Feng-Ching</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Curie, PSL Research University, CNRS UMR168, Physics of Cells and Cancer Laboratory</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Obadia</surname><given-names>Thomas</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics Hub</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff><institution>Institut Pasteur, Université Paris Cité, G5 Infectious Diseases Epidemiology and Analytics</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Srivastava</surname><given-names>Nishit</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Curie and Institut Pierre Gilles de Gennes, PSL Research University, Sorbonne University</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Marechal</surname><given-names>Maud</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur, Université Paris Cité, CNRS UMR6047, Inserm U1306, Unité des Toxines Bactériennes, Département de Microbiologie</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Salles</surname><given-names>Audrey</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur, Université Paris Cité, PhotonicBio-Imaging, Centre de Ressources et Recherches Technologiques (UTechS-PBI,C2RT)</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Albert</surname><given-names>Marvin</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur, Université Paris Cité, Image Analysis Hub</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Stefani</surname><given-names>Caroline</given-names></name><role specific-use="author">Author</role><aff><institution>Benaroya Research Institute at Virginia Mason, Departmentof Immunology</institution><addr-line><named-content content-type="city">Seattle</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Benito</surname><given-names>Yvonne</given-names></name><role specific-use="author">Author</role><aff><institution>Centre National de Référence des Staphylocoques, Hospices Civiles de Lyon</institution><addr-line><named-content content-type="city">Lyon</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Vandenesch</surname><given-names>François</given-names></name><role specific-use="author">Author</role><aff><institution>CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon</institution><addr-line><named-content content-type="city">Lyon</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Lamaze</surname><given-names>Christophe</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Curie, PSL Research University, INSERM U1143, CNRS UMR3666, Membrane Mechanics and Dynamics of Intracellular Signaling Laboratory</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Vassilopoulos</surname><given-names>Stéphane</given-names></name><role specific-use="author">Author</role><aff><institution>Sorbonne Université, INSERM UMR974, Institut de Myologie, Centre de Recherche en Myologie</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Piel</surname><given-names>Matthieu</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Curie and Institut Pierre Gilles de Gennes, PSL Research University, Sorbonne University</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Bassereau</surname><given-names>Patricia</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Curie, PSL Research University, CNRS UMR168, Physics of Cells and Cancer Laboratory</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Gonzalez-Rodriguez</surname><given-names>David</given-names></name><role specific-use="author">Author</role><aff><institution>Université de Lorraine, LCP-A2MC</institution><addr-line><named-content content-type="city">Metz</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Leduc</surname><given-names>Cecile</given-names></name><role specific-use="author">Author</role><aff><institution>Université Paris Cité, Institut Jacques Monod, CNRS UMR7592</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Lemichez</surname><given-names>Emmanuel</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur, Université Paris Cité, CNRS UMR6047, Inserm U1306, Unité des Toxines Bactériennes, Département de Microbiologie</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><p>We thank the Editors and the Reviewers for their comments on the importance of our work “showing a new role of caveolin-1 as an individual protein instead of the main molecular component of caveolae” in contributing to membrane bending rigidity and for constructive and thoughtful remarks that have allowed us to improve the manuscript.</p><p>Indeed, we here establish the contributing role of caveolin-1 to membrane mechanics by a molecular mechanism that needs to be further addressed. To that respect, we thank the reviewers for suggesting avenues to improve the presentation and discussion of our hypotheses based on results of theoretical model and independent biophysical measurements of membrane mechanics in tube pulling from plasma membrane spheres, which concur to support the key role of caveolin-1 in building membrane bending rigidity.</p><p>To fulfill the recommendations of the reviewers we have modified the manuscript, as discussed below.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>Because of the role of membrane tension in the process, and that caveloae regulate membrane tension, the authors looked at the formation of TEMs in cells depleted of Caveolin1 and Cavin1 (PTRF): They found a higher propensity to form TEMs, spontaneously (a rare event) and after toxin treatment, in both Caveolin 1 and Cavin 1. They show that in both siRNA-Caveolin1 and siRNA-Cavin1 cells, the cytoplasm is thinner. They show that in siCaveolin1 only, the dynamics of opening are different, with notably much larger TEMs. From the dynamic model of opening, they predict that this should be due to a lower bending rigidity of the membrane. They measure the bending rigidity from Cell-generated Giant liposomes and find that the bending rigidity is reduced by approx. 50%.</p><p>Strengths:</p><p>They also nicely show that caveolin1 KO mice are more susceptible to death from infections with pathogens that create TEMs.</p><p>Overall, the paper is well-conducted and nicely written. There are however a few details that should be addressed.</p></disp-quote><p>See below modifications brought to the manuscript in response to the Reviewer’s remarks.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>The manuscript by Morel et al. aims to identify some potential mechano-regulators of transendothelial cell macro-aperture (TEM). Guided by the recognized role of caveolar invaginations in buffering the membrane tension of cells, the authors focused on caveolin-1 and associated regulator PTRF. They report a comprehensive <italic>in vitro</italic> work based on siRNA knockdown and optical imaging approach complemented with an <italic>in vivo</italic> work on mice, a biophysical assay allowing measurement of the mechanical properties of membranes, and a theoretical analysis inspired by soft matter physics.</p><p>Strengths:</p><p>The authors should be complimented for this multi-faceted and rigorous work. The accumulation of pieces of evidence collected from each type of approach makes the conclusion drawn by the authors very convincing, regarding the new role of cavolin-1 as an individual protein instead of the main molecular component of caveolae. On a personal note, I was very impressed by the quality of STORM images (Fig. 2) which are very illuminating and useful, in particular for validating some hypotheses of the theoretical analysis.</p><p>Weaknesses:</p><p>While this work pins down the key role of caveolin-1, its mechanism remains to be further investigated. The hypotheses proposed by the authors in the discussions about the link between caveolin and lipids/cholesterol are very plausible though challenging. Even though we may feel slightly frustrated by the absence of data in this direction, the quality and merit of this paper remain.</p></disp-quote><p>We thank the reviewer for mentioning the merit of our work which lays the foundations for more molecular mechanistic work on a possible role of lipids/cholesterol in the building of membrane bending rigidity by caveolin-1 and which is currently carried out by some of the authors, and which shows that the question is indeed challenging as indicated by the reviewer. This is now stated in the results section, as suggested (Page 12) :</p><p>&quot;To test these predictions, we have treated cells with methyl-beta-cyclodextrin to deplete cholesterol from the plasma membrane and reduce its bending rigidity (47); unfortunately, this treatment affected the cell morphology, which precluded further analysis.&quot;</p><disp-quote content-type="editor-comment"><p>The analogy with dewetting processes drawn to derive the theoretical model is very attractive. However, although part of the model has already been published several times by the same group of authors, the definition of the effective membrane rigidity of a plasma membrane including the underlying actin cortex, was very vague and confusing.</p></disp-quote><p>We thank the reviewer for mentioning the importance of defining the terms “membrane bending rigidity” as well as “effective membrane bending rigidity” that is now used and defined in the material and method section in the Physical modelling description (see considerations below), while for the sake of simplicity we use the term “membrane bending rigidity” in the main text, which is now defined in the introduction section : “membrane bending rigidity, i.e. the energy required to locally bend the membrane surface”.</p><p>Indeed, in a liposome, a rigorous derivation leads to a relationship between the membrane tension and the variation of the projected area, which are related by the bending rigidity: this relationship is known as the Helfrich’s law. This statistical physics approach is only rigorously valid for a liposome, whereas its application to a cell is questionable due to the presence of cytoskeletal forces acting on the membrane. Nevertheless, application of the Helfrich’s law to cell membranes may be granted on short time scales, before active cell tension regulation takes place (Sens P and Plastino J, 2015 J Phys Condens Matter), especially in cases where cytoskeletal forces play a modest role, such as red blood cells (Helfrich W 1973 Z Naturforsch C). The fact that the cytoskeletal structure and actomyosin contraction are significantly disrupted upon cell intoxication-driven inhibition of the small GTPase RhoA, as shown here for the first time by STORM analysis, supports the applicability of Helfrich’s law to describe TEM opening. Because of the presence of proteins, carbohydrates, and the adhesion of the remaining actin meshwork after toxin treatment, we expect the Helfrich relationship to somewhat differ from the case of a pure lipidic membrane. We account for these effects via an “effective bending rigidity”, a term used in the detailed discussion of the model hypotheses, which corresponds to an effective value describing the relationship between membrane tension and projected area variation in our cells.</p><p>The following discussion has been extended and improved in the Physical modeling part of the materials &amp; methods section (Pages 23-24): “κ is the effective bending rigidity of the cell membrane, which quantifies the energy required to bend the membrane. (…). While rigorously derived for a pure lipid membrane, we assumed that Helfrich’s law is applicable to describe the relationship between the effective membrane tension acting on TEMs and the observed projected surface in our cells. We expect Helfrich’s law to be applicable on short time scales, before active cell tension regulation takes place (73), especially in cases where cytoskeletal forces play a modest role, such as for red blood cells (74) or for the highly disrupted cytoskeletal structure of our intoxicated cells. Thus, the parameter κ in Eq. 2 is an effective bending rigidity, whose value may somewhat differ from that of a pure lipid membrane to account for the role played by protein inclusions and the mechanical contribution of the remaining cytoskeletal elements after cell treatment with the toxin”</p><disp-quote content-type="editor-comment"><p>Here, for the first time, thanks to the STORM analysis, the authors show that HUVECs intoxicated by ExoC3 exhibit a loose and defective cortex with a significantly increased mesh size. This argues in favor of the validity of Helfrich formalism in this context. Nonetheless, there remains a puzzle. Experimentally, several TEMs are visible within one cell. Theoretically, the authors consider a simultaneous opening of several pores and treat them in an additive manner. However, when one pore opens, the tension relaxes and should prevent the opening of subsequent pores. Yet, experimentally, as seen from the beautiful supplementary videos, several pores open one after the other. This would suggest that the tension is not homogeneous within an intoxicated cell or that equilibration times are long. One possibility is that some undegraded actin pieces of the actin cortex may form a barrier that somehow isolates one TEM from a neighboring one.</p></disp-quote><p>As pointed by the Reviewer, we expect that membrane tension is neither a purely global nor a purely local parameter. Opening of a TEM will relax membrane tension over a certain distance, not over the whole cell. Moreover, once the TEM closes back, membrane tension will increase again. This spatial and temporal localization of membrane tension relaxation explains that the opening of a first TEM does not preclude the opening of a second one or enlargement of the TEM when the actin cable is cut by laser ablation (20). On the other hand, membrane tension is not a purely local property. Indeed, we observe that when two TEMs enlarge next to each other, their shape becomes anisotropic, as their enlargement is mutually hampered in the region separating them. We account for this interaction by treating TEM membrane relaxation in an additive fashion. We emphasize that this simplified description is used to predict maximum TEM size, corresponding to the time at which TEM interaction is strongest. As the reviewer points out, it would be more questionable to use this additive treatment to predict the likelihood of nucleation of a new TEM, which is not done here.</p><p>Accordingly, the Physical modelling part in the materiel and methods has been modified into: “Eq. 2 treats the effect of several simultaneous TEMs in an additive manner. This approximation is used here to predict TEM size, because at maximum opening of simultaneous TEMs their respective membrane relaxation is felt by each other, as it can be inferred from the shape that neighboring TEMs adopt in experiments. This additive treatment would appear less appropriate to describe the likelihood of nucleating a second TEM in the presence of a first one (a calculation that is not performed here), since membrane relaxation by a TEM may not be felt at membrane regions distant from it.”</p><disp-quote content-type="editor-comment"><p>Could the authors look back at their STORM data and check whether intoxicated cells do not exhibit a bimodal population of mesh sizes and possibly provide a mapping of mesh size at the scale of a cell?</p></disp-quote><p>To address the question raised by the Reviewer we decided to plot the whole distribution of mesh sizes in addition to the average value per cell. We did not observe a bimodal distribution but rather a very heterogeneous distribution of mesh size going up to a few microns square in all conditions of siRNA treatments. Moreover, we did not observe a specific pattern in the distribution of mesh size at the scale of the cell, with very large mesh sizes being surrounded by small ones. We also did not observe any specific pattern for the localization of TEM opening, as described in the paper, making the correlation between mesh size and TEM opening difficult.</p><p>This following sentence has been added in the results section (Pages 8-9): “Indeed, we observed in cells treated with ExoC3 no specific cellular pattern or bimodal distribution of mesh size between the different siRNA conditions but a rather very heterogeneous distribution of mesh size values that could reach a few square microns in all conditions. ”</p><disp-quote content-type="editor-comment"><p>In particular, it is quite striking that while bending rigidity of the lipid membrane is expected to set the maximal size of the aperture, most TEMs are well delimited with actin rings before closing. Is it because the surrounding loose actin is pushed back by the rim of the aperture? Could the authors better explain why they do not consider actin as a player in TEM opening?</p></disp-quote><p>Actin ring assembly and stiffening is indeed a player in TEM opening, that was investigated in the work by Stefani et al., 2017 Nat comm. Interference of actin ring assembly and stiffening is included in our differential equation describing TEM opening dynamics (second term on the left-hand side of Eq. 3). In some cases, actin ring assembly is the dominant player, such as in TEM opening after laser ablation (ex novo TEM opening/widening). In contrast, here we investigate de novo TEM opening, for which we expect that bending rigidity can be estimated without accounting for actin assembly, as we previously reported (19). Such a bending rigidity estimate (Eq. 5) is obtained by considering two different time scales: the time scale of membrane tension relaxation, governed by bending rigidity, and the time scale of cable assembly, governed by actin dynamics. We expect the first time scale to be shorter, and thus the maximum size of de novo TEMs to be mainly constrained by membrane tension relaxation. Two paragraphs related to the discussion of the different time scales have been added to (1) the discussion section, and (2) to the physical modelling part discussed in the materiel and methods section of the revised manuscript (see below).</p><p>The following paragraph has been added in the discussion (Pages 14-15): “Our study shows that membrane rigidity sets the maximal size of TEM aperture, although an actin ring appears before TEM closure (20). Actin ring assembly and stiffening is indeed a player in TEM opening, and it is included in our differential equation describing TEM opening dynamics (Eq. 3). In some configurations, actin ring assembly is the dominant player, such as in TEM opening after laser ablation (ex novo TEM opening), as we previously reported (20). In contrast, here we investigate de novo TEM opening, for which we expect that bending rigidity can be estimated without accounting for actin assembly (19). Such a bending rigidity estimate (Eq. 5) is obtained by considering two different time scales: the time scale of membrane tension relaxation, governed by bending rigidity, and the time scale of cable assembly, governed by actin dynamics. We expect the first-time scale to be shorter, and thus the maximum size of de novo TEMs to be mainly constrained by membrane tension relaxation. However, we cannot rule out that the formation of an actin cable around the TEM before it reaches its maximum size may limit the correct estimation of the bending rigidity.”</p><p>The following paragraph has been added in the physical modelling part of the materiel and methods section (Pages 24-25) “A limitation of our theoretical description arises from the use of spatially uniform changes in parameter values to describe differences between experimental conditions, thus assuming spatially uniform effects. However, we cannot exclude the existence of non-uniform effects, such as changes in the size and organization of the remaining actin mesh, which could set local, non-uniform barriers to TEM enlargement in a manner not accounted for by our model.” And “We note that the estimate of κ provided by Eq. 5 is independent of α and thus of actin cable assembly. This simplification arises from membrane tension relaxing over a shorter time scale than actin assembly. Thus, we expect the maximum size of de novo TEMs to be mainly constrained by membrane tension relaxation (19), unlike ex novo TEM enlargement upon laser ablation, for which the dynamics of actin cable assembly control TEM opening (20)”</p><disp-quote content-type="editor-comment"><p>Instead of delegating to the discussion the possible link between caveolin and lipids as a mechanism for the enhanced bending rigidity provided by caveolin-1, it could be of interest for the readership to insert the attempted (and failed) experiments in the result section. For instance, did the authors try treatment with methyl-beta-cyclodextrin that extracts cholesterol (and disrupts caveolar and clathrin pits) but supposedly keeps the majority of the pool of individual caveolins at the membrane?</p></disp-quote><p>As recommended by the reviewer we have added the following sentence (Page 12): “We have treated cells with methyl-beta-cyclodextrin to deplete cholesterol from the plasma membrane and reduce its bending rigidity (47); unfortunately, this treatment affected the cell morphology, which precluded further analysis”</p><disp-quote content-type="editor-comment"><p>Tether pulling experiments on Plasma membrane spheres (PMS) are real tours de force and the results are quite convincing: a clear difference in bending rigidity is observed in controlled and caveolin knock-out PMS. However, one recurrent concern in these tether-pulling experiments is to be sure that the membrane pulled in the tether has the same composition as the one in the PMS body. The presence of the highly curved neck may impede or slow down membrane proteins from reaching the tether by convective or diffusive motion.</p></disp-quote><p>We thank the Reviewer for mentioning the dedicated work accomplished with tether pulling experiments on PMS and for pointing the obtention of convincing results that align well with the hypotheses drawn from the theoretical model thereby allowing us to propose a direct or indirect role of caveolin-1 in the building of membrane rigidity. As pointed out by the reviewer, a concern with tube pulling experiments is related to the dynamics of equilibration of membrane composition between the nanotube and the rest of the membrane. In our experiments, we have waited about 30 seconds after tube pulling and after changing membrane tension. We have checked that after this time, the force remained constant, implying that we have performed experiments of tube pulling from PMS in technical conditions of equilibrium that ensure that lipids and membrane proteins had enough time to reach the tether by convective or diffusive motion.</p><p>The revised version of the manuscript now includes the following sentence and a representative example of force vs time plot (Page 12): “We waited about 30 seconds after tube pulling and changing membrane tension and checked that we reached a steady state (Fig. S5), where lipids and membrane proteins had enough time to equilibrate.”</p><disp-quote content-type="editor-comment"><p>Could the authors propose an experiment to demonstrate that caveolin-1 proteins are not restricted to the body of the PMS and can access to the nanometric tether?</p></disp-quote><p>In principle, this could be further checked using cells expressing GFP-caveolin-1 to generate PMS as done in Sinha et al., 2011 and by analyzing a steady protein signal in the tube. This would confirm the equilibration, provided that caveolin-1 is recruited in the nanotube due to mechanical reasons that are now discussed in the discussion section (Pages 13-14) : “Our tube pulling experiments can be discussed along 2 lines. Indeed, since caveolin-1 is inserted in the cytosolic leaflet of the plasma membrane, when a nanotube is pulled towards the exterior of the PMS, we can expect 2 situations depending on the ability of caveolin-1 to deform membranes, which remains to be addressed (24). (i) If Cav1 does not bend membranes, it could be recruited in the nanotube at a density similar to the PMS and our force measurement would reflect the bending rigidity of the PMS membrane. Cav1 could then stiffen membrane either as a stiff inclusion at high density or/and by affecting lipid composition. (ii) If Cav1 bends the membrane, it is expected from caveolae geometry that the curvature in the tube would favor Cav1 exclusion. The force would then reflect the bending rigidity of the membrane depleted of Cav1, which should be the same in both types of experiments (WT and Cav1-depleted conditions) if the lipid composition remains unchanged upon Cav1 depletion. Note that the presence of a very reduced concentration of Cav1 as compared to the plasma membrane has been reported in tunneling nanotubes (TNT) connecting two neighboring cells (51). These TNTs have typical diameters of similar scale than diameters of tubes pulled from PMS. At this stage, we cannot decipher between both properties for Cav1. Considering a direct mechanical role of Cav1, previous studies showed that inclusion of integral proteins in membranes had no impact on bending rigidity, as shown in the bacteriorhodopsin experiment (52), or even decreased membrane rigidity as reported for the Ca2+-ATPase SERCA (53). Previous simulations have also confirmed the softening effect of protein inclusions (54). Nevertheless, our observations could be explained by a high density of stiff inclusions in the plasma membrane (&gt;&gt;10%), which is generally not achievable with the reconstituted membranes. Considering an impact on lipid composition, it is well established that caveolae are enriched with cholesterol, sphingomyelin, and glycosphingolipids, including gangliosides (55,56), which are known to rigidify membranes (57,47). Thus, caveolin-1 might contribute to the enrichment of the plasma membrane with these lipid species. We did not establish experimental conditions allowing us to deplete cholesterol without compromising the shape of HUVECs, which prevented a proper analysis of TEM dynamics. Moreover, a previous attempt to increase TEMs width by softening the membrane through the incorporation of poly-unsaturated acyl chains into phospholipids failed, likely due to homeostatic adaptation of the membrane’s mechanical properties (18). Further studies are now required to establish whether and how caveolin-1 oligomers control membrane mechanical parameters through modulation of lipids organization or content. Caveolin-1 expression may also contribute to plasma membrane stiffening by interacting with membrane-associated components of the cortical cytoskeletal or by structuring ordered lipid domains. Nevertheless, it has been reported that the Young’s modulus of the cell cortex dramatically decreases in ExoC3-treated cells (17) suggesting a small additional contribution of caveolin-1 depletion to membrane softening. This is supported by 2D STORM data showing a dramatic reorganization of actin cytoskeleton in ExoC3-treated cells into a loose F-actin meshwork that is not significantly exacerbated by caveolin-1 depletion. Altogether, our results suggest that the presence of Cav1 stiffens plasma membranes, and that the exact origin of this effect must be further investigated.”</p><disp-quote content-type="editor-comment"><p><bold>Author recommendations</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>Suggestions for improvements:</p><p>(1) Depletion of both Cavin1 and Caveolin1 increases the density of TEMs. Membrane tension is a critical parameter of the initiation phase of TEMs, its nucleation, and initial enlargement. From the TEM dynamics, the authors should be able to measure membrane tension. The expectation is that in both Caveolin1 and Cavin1 depleted cells, tension is higher (because there is no caveolae), explaining why there are more TEMs.</p></disp-quote><p>While we cannot directly measure membrane tension, we can estimate membrane tension variations using our theoretical modeling. As reported in the article, we predict that depleting Caveolin-1 leads to a significant 2-fold increase of membrane tension, which can explain the concomitant increase in the nucleation of TEMs, as the reviewer points out. In contrast, the model predicts no significant increase of membrane tension upon Cavin-1/PTRF depletion, whereas TEM nucleation also increases significantly (but less than upon Caveolin-1 depletion). Altogether, we can explain these results by considering that membrane tension is an important player in TEM nucleation, but not the only one. Notably, we expect cell height to be another important player, as it sets an energy barrier for the basal and apical membranes to meet each other and fuse. Indeed, we report that membrane height is reduced upon depletion Cavin-1, thus explaining the observed increase in TEM nucleation. The importance of reducing cell thickness to increase the TEM opening likelihood is best supported by previous data showing that pushing forces applied on the apical membrane induced the opening of TEMs (Ng et al., 2017 MBoC).</p><p>An improved discussion of the parameters controlling TEM nucleation has been included in the discussion of the revised manuscript, as follow (Page 15): “Our study points to underlying mechanisms by which caveolae regulate the frequency of TEM nucleation. Nucleation of TEMs requires the apposition of the basal and apical cell membranes, which is hindered by the intermembrane distance, set by the cell height. Meeting of the two membranes may create an initial precursor tunnel, which needs to be sufficiently big to enlarge into an observable TEM, instead of simply closing back. The size of the minimal precursor tunnel required to give rise to a TEM increases with membrane bending rigidity and decreases with membrane tension (19). Silencing cavin-1 or caveolin-1 both lead to a decrease in cell height, thus favoring the likelihood of precursor tunnel nucleation. While silencing cavin-1 has no significant impact on either membrane tension or bending rigidity, silencing caveolin results in both an increase of membrane tension and a decrease of bending rigidity, which results in a decrease in the required minimal radius of the precursor tunnel, thus further favoring TEM nucleation. Overall, our results offer a consistent picture of the physical mechanisms by which caveolae modulate TEM nucleation.”</p><disp-quote content-type="editor-comment"><p>(2) In Figure 2B, the authors state that there is no significant difference in the actin mesh size while I see a clear higher average value and distribution in siCAV1+. This seems to correlate with the differences in TEM maximal sizes. How can the authors completely exclude that the actin organisation is not in part responsible for the larger TEMs observed in siCAV1 cells?</p></disp-quote><p>In our theoretical modeling of TEM opening dynamics, all differences between conditions are described by changes in what we consider as “effective” parameter values. Thus, changes in actin organization may induce a change in the &quot;effective bending rigidity&quot; parameter controlling membrane tension relaxation. A limitation of such a description is that all changes are assumed to be spatially uniform. However, it is possible that changes in actin mesh size and organization set local barriers to TEM enlargement in a way that would not be appropriately described by our model. While our current modeling appears to provide a consistent interpretation of our observations, we cannot completely exclude the existence of such local effects.</p><p>This limitation of our current interpretation is now mentioned in the following paragraph, which has been added in the physical modelling part of the materiel and methods section (Page 24) : “A limitation of our theoretical description arises from the use of spatially uniform changes in parameter values to describe differences between experimental conditions, thus assuming spatially uniform effects. However, we cannot exclude the existence of non-uniform effects, such as changes in the size and organization of the remaining actin mesh, which could set local, non-uniform barriers to TEM enlargement in a manner not accounted for by our model.”</p><disp-quote content-type="editor-comment"><p>(3) It would be nice to see the results of Table 1 (in particular the thickness of cells) in a Bar plot.</p></disp-quote><p>The experimental values of cell volumes and areas are reported in bar plots of Fig. 3C and 3D. In contrast, we chose not to depict values of cell eight in bar plots considering that these values were calculated from mean values of cell areas and volumes reported in Fig. 3C and 3D, i.e. rough division of volumes over areas, with error propagation. Since the volume and areas are not performed on the same set of cells, it is not possible to divide the repeats one by one and to provide cell numbers, which are key parameters to perform statistical tests.</p><disp-quote content-type="editor-comment"><p>(4) There are two reasons why Caveolin1 could change the bending rigidity. First, because it makes the membrane stiffer, or because the presence of caveolin1 (that binds to cholesterol) in the plasma membrane changes the lipid composition. It would be nice if the authors could provide some lipidomics analysis to see if there is a lipid change in siCAV1 cells.</p></disp-quote><p>We thank the reviewer for pointing the importance of clarifying the hypotheses regarding a direct or indirect role of caveolin-1 in membrane bending rigidity which might be related to changes in membrane lipid composition especially cholesterol and sphingomyelin. We have modified the discussion section to integrate this point. The lipidomic approach is certainly interesting to address the question of the role of caveolin-1 in building membrane bending rigidity. Indeed, some of the authors have addressed the specific questions related to Cav-1 spontaneous curvature and its effect on the lipid composition of the plasma membrane in two separate manuscripts (in preparation). They represent comprehensive studies by themselves that will provide mechanistic insights on how caveolin-1 builds membrane bending rigidity and as follow up of the present manuscript which reports the importance of the regulation of membrane rigidity in cell biology and during infectious processes.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>The paper is nicely written and the results are convincing. The three main comments and questions from the Public Review do not necessarily call for new experiments. However, clarifications are required. This work can be very useful. Better not to leave any difficulty or weakly justified hypothesis under the carpet.</p></disp-quote><p>To fulfill with the reviewer comments, we have improved the discussion regarding the hypothesizes which can be drawn about of a direct versus indirect mechanistic role of caveolin-1 in the regulation of effective membrane bending rigidity and which might be related to changes in membrane lipid composition or via regulation of the cytoskeleton, which we cannot exclude.</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>Minor correction: in the abstract: replace &quot;the enhanced nucleation&quot; with &quot;the enhanced occurrence of nucleation events&quot;.</p></list-item></list></disp-quote><p>The abstract has been changed accordingly : “The enhanced occurrence of TEM nucleation events correlates with a reduction of cell height, …”</p></body></sub-article></article>